General Information of Drug (ID: DM5T6US)

Drug Name
Estrone Drug Info
Synonyms
Aquacrine; Crinovaryl; Cristallovar; Crystogen; Destrone; Disynformon; Endofolliculina; Esterone; Estrin; Estrol; Estron; Estrona; Estronum; Estrovarin; Estrugenone; Estrusol; Femidyn; Fermidyn; Folikrin; Folipex; Folisan; Follestrine; Follestrol; Folliculin; Folliculine; Follicunodis; Glandubolin; Hiestrone; Hormestrin; Hormofollin; Hormovarine; Kestrone; Ketodestrin; Ketohydroxyestrin; Ketohydroxyoestrin; Ketophydroxyestrin; Kolpon; Menagen; Menformon; Mestronaq; OESTRONE; Oestrin; Oestroform; Oestronum; Oestroperos; Ovifollin; Perlatan; Solliculin; Theelin; Thelestrin; Thelykinin; Thynestron; Tokokin; Unden; Unigen; Wehgen; Wynestron; Estrogenic Substance; Estrona [Spanish]; Femestrone injection; Follicular hormone; Folliculine benzoate; Hauck Brand of Estrone; Hyrex Brand of Estrone; Menformon A; Oestrone [Steroidal oestrogens]; Penncap M; Vortech Brand of Estrone; WynestronPencap M; CMC_13458; E 9750; E0026; E(sub 1); Estrona [INN-Spanish]; Estrone (E1); Estrone (TN); Estrone [USAN:INN]; Estrone-A; Estronum [INN-Latin]; Femestrone inj.; Ketohydroxy-Estratriene; NATURAL ESTROGENIC SUBSTANCE-ESTRONE; Oestrone, Estrone; Ovex (tablets); Unden (pharmaceutical); Unden (pharmaceutical) (VAN); Estrone (JAN/USP/INN); Estrone, (8 alpha)-Isomer; Estrone, (9 beta)-Isomer; Estrone, (+-)-Isomer; [2,4,6,7-3H]-E1; Delta-1,3,5-Estratrien-3beta-ol-17-one; Delta-1,3,5-Oestratrien-3beta-ol-17-one; Delta-1,3,5-estratrien-3-beta-ol-17-one; Delta-1,3,5-oestratrien-3-beta-ol-17-one; (13S)-3-hydroxy-13-methyl-7,8,9,11,12,13,15,16-octahydro-6H-cyclopenta[a]phenanthren-17(14H)-one; (8R,9S,13S,14S)-3-hydroxy-13-methyl-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthren-17-one; 1,3,5(10)-Estratrien-3-ol-17-one; 1,3,5(10)-Oestratrien-3-ol-17-one; 3-Hydroxy-1,3,5(10)-estratrien-17-one; 3-Hydroxy-17-keto-estra-1,3,5-triene; 3-Hydroxy-17-keto-oestra-1,3,5-triene; 3-Hydroxy-oestra-1,3,5(10)-trien-17-one; 3-Hydroxyestra-1,3,5(10)-trien-17-one; 3-Hydroxyestra-1,3,5(10)-triene-17-one; 3-hydroxy-estra-1,3,5(10)-trien-17-one
Indication
Disease Entry ICD 11 Status REF
Acne vulgaris ED80 Approved [1]
Menopausal and postmenopausal disorder GA30 Approved [2]
Therapeutic Class
Antimenopausal Agents
Cross-matching ID
PubChem CID
5870
ChEBI ID
CHEBI:17263
CAS Number
CAS 53-16-7
TTD Drug ID
DM5T6US
VARIDT Drug ID
DR00494
INTEDE Drug ID
DR0648

Molecule-Related Drug Atlas

Molecule-Related Drug Atlas
Molecule Type:
DTT
DTP
DME
DOT
Drug Status:
Approved Drug(s)
Clinical Trial Drug(s)
Investigative Drug(s)
Patented Agent(s)
Drug(s) Targeting Estrogen receptor (ESR)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Tamoxifen DMLB0EZ Breast cancer 2C60-2C65 Approved [19]
Estradiol DMUNTE3 Acne vulgaris ED80 Approved [3]
Estradiol Valerate DM8MC6O Hormone replacement therapy 8E01 Approved [20]
Estradiol Acetate DM07U2A Hormone replacement therapy 8E01 Approved [20]
Estradiol Cypionate DM27Z5T Hormone replacement therapy 8E01 Approved [20]
Ethinyl Estradiol DMODJ40 Acne vulgaris ED80 Approved [21]
Raloxifene DMDKF3M Osteoporosis FB83.0 Approved [22]
Ospemifene DMC4GEI Dyspareunia GA12 Approved [23]
Toremifene DMQYUWG Breast cancer 2C60-2C65 Approved [24]
Mestranol DMG3F94 Contraception QA21 Approved [25]
⏷ Show the Full List of 10 Drug(s)
Drug(s) Transported By P-glycoprotein 1 (ABCB1)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Amoxicillin DMUYNEI Acute otitis media AB00 Approved [26]
Doxorubicin DMVP5YE Acute myelogenous leukaemia 2A41 Approved [27]
Methotrexate DM2TEOL Anterior urethra cancer Approved [28]
Folic Acid DMEMBJC Colorectal carcinoma Approved [29]
Fluorouracil DMUM7HZ Adenocarcinoma 2D40 Approved [28]
Cisplatin DMRHGI9 Adenocarcinoma 2D40 Approved [28]
Progesterone DMUY35B Amenorrhea GA20.0 Approved [30]
Tamoxifen DMLB0EZ Breast cancer 2C60-2C65 Approved [28]
Estradiol DMUNTE3 Acne vulgaris ED80 Approved [31]
Imatinib DM7RJXL Acute lymphoblastic leukaemia 2A85 Approved [32]
⏷ Show the Full List of 10 Drug(s)
Drug(s) Metabolized By Cytochrome P450 3A4 (CYP3A4)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Doxorubicin DMVP5YE Acute myelogenous leukaemia 2A41 Approved [33]
Progesterone DMUY35B Amenorrhea GA20.0 Approved [34]
Tamoxifen DMLB0EZ Breast cancer 2C60-2C65 Approved [35]
Estradiol DMUNTE3 Acne vulgaris ED80 Approved [36]
Acetaminophen DMUIE76 Allergic rhinitis CA08.0 Approved [37]
Imatinib DM7RJXL Acute lymphoblastic leukaemia 2A85 Approved [38]
Etoposide DMNH3PG Acute myelogenous leukaemia 2A41 Approved [39]
Zidovudine DM4KI7O Human immunodeficiency virus infection 1C62 Approved [40]
Prasterone DM67VKL Chronic obstructive pulmonary disease CA22 Approved [34]
Verapamil DMA7PEW Angina pectoris BA40 Approved [41]
Eplerenone DMF0NQR Heart failure BD10-BD13 Approved [101]
Cannabidiol DM0659E Dravet syndrome 8A61.11 Approved [102]
Isotretinoin DM4QTBN Acne vulgaris ED80 Approved [103]
Voriconazole DMAOL2S Aspergillosis 1F20 Approved [104]
Proguanil DMBL79I Malaria 1F40-1F45 Approved [105]
Ivermectin DMDBX5F Intestinal strongyloidiasis due to nematode parasite 1F6B Approved [105]
Loratadine DMF3AN7 Allergy 4A80-4A85 Approved [106]
Nelfinavir mesylate DMFX6G8 N. A. N. A. Approved [107]
Capsaicin DMGMF6V Back pain ME84.Z Approved [108]
Axitinib DMGVH6N Renal cell carcinoma 2C90 Approved [109]
⏷ Show the Full List of 20 Drug(s)
Drug(s) Metabolized By Cytochrome P450 1A2 (CYP1A2)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Fluorouracil DMUM7HZ Adenocarcinoma 2D40 Approved [42]
Dinoprostone DMTYOPD Medical abortion JA00.1Z Approved [43]
Tamoxifen DMLB0EZ Breast cancer 2C60-2C65 Approved [44]
Estradiol DMUNTE3 Acne vulgaris ED80 Approved [45]
Acetaminophen DMUIE76 Allergic rhinitis CA08.0 Approved [46]
Imatinib DM7RJXL Acute lymphoblastic leukaemia 2A85 Approved [47]
Etoposide DMNH3PG Acute myelogenous leukaemia 2A41 Approved [39]
Oxaliplatin DMQNWRD Adenocarcinoma 2D40 Approved [48]
Verapamil DMA7PEW Angina pectoris BA40 Approved [49]
Diclofenac DMPIHLS Chronic renal failure GB61.Z Approved [50]
Zolmitriptan DM1IB4Q Migraine 8A80 Approved [110]
Rofecoxib DM3P5DA Osteoarthritis FA00-FA05 Approved [110]
Etoricoxib DM6A4NW Rheumatoid arthritis FA20 Approved [110]
Capsaicin DMGMF6V Back pain ME84.Z Approved [111]
Hesperetin DMKER83 High blood cholesterol level 5C80.00 Approved [112]
Stiripentol DMMSDOY Dravet syndrome 8A61.11 Approved [113]
Nifedipine DMSVOZT Angina pectoris BA40 Approved [114]
Zileuton DMVRIC2 Allergic asthma CA23.0 Approved [115]
Nicotine DMWX5CO Lung cancer 2C25.0 Approved [116]
Clonidine DM6RZ9Q Attention deficit hyperactivity disorder 6A05.Z Approved [117]
⏷ Show the Full List of 20 Drug(s)
Drug(s) Metabolized By Cytochrome P450 1A1 (CYP1A1)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Progesterone DMUY35B Amenorrhea GA20.0 Approved [51]
Tamoxifen DMLB0EZ Breast cancer 2C60-2C65 Approved [52]
Estradiol DMUNTE3 Acne vulgaris ED80 Approved [53]
Acetaminophen DMUIE76 Allergic rhinitis CA08.0 Approved [54]
Oxaliplatin DMQNWRD Adenocarcinoma 2D40 Approved [48]
Diclofenac DMPIHLS Chronic renal failure GB61.Z Approved [55]
Erythromycin DM4K7GQ Acne vulgaris ED80 Approved [56]
Riboflavin DM8YMWE Acne vulgaris ED80 Approved [57]
Mercaptopurine DMTM2IK Acute lymphoblastic leukaemia 2A85 Approved [58]
Nicotine DMWX5CO Lung cancer 2C25.0 Approved [59]
Amodiaquine DME4RA8 Malaria 1F40-1F45 Approved [144]
Riluzole DMECBWN Amyotrophic lateral sclerosis 8B60.0 Approved [145]
Flutamide DMK0O7U Prostate cancer 2C82.0 Approved [146]
Menadione DMSJDTY Vitamin K deficiency 5B59 Approved [147]
Estradiol DMUNTE3 Acne vulgaris ED80 Approved [148]
Troglitazone DM3VFPD Diabetic complication 5A2Y Approved [149]
Ethacrynic acid DM60QMR Edema MG29 Approved [150]
Marinol DM70IK5 Anorexia nervosa cachexia 6B80 Approved [151]
Ethinyl Estradiol DMODJ40 Acne vulgaris ED80 Approved [152]
Clofibrate DMPC1J7 Dysbetalipoproteinemia 5C80.2 Approved [153]
⏷ Show the Full List of 20 Drug(s)
Drug(s) Metabolized By Cytochrome P450 3A5 (CYP3A5)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Doxorubicin DMVP5YE Acute myelogenous leukaemia 2A41 Approved [60]
Progesterone DMUY35B Amenorrhea GA20.0 Approved [61]
Tamoxifen DMLB0EZ Breast cancer 2C60-2C65 Approved [62]
Estradiol DMUNTE3 Acne vulgaris ED80 Approved [63]
Acetaminophen DMUIE76 Allergic rhinitis CA08.0 Approved [64]
Sulfasalazine DMICA9H Irritable bowel syndrome DD91.0 Approved [65]
Imatinib DM7RJXL Acute lymphoblastic leukaemia 2A85 Approved [66]
Etoposide DMNH3PG Acute myelogenous leukaemia 2A41 Approved [67]
Verapamil DMA7PEW Angina pectoris BA40 Approved [68]
Sorafenib DMS8IFC Adenocarcinoma 2D40 Approved [63]
⏷ Show the Full List of 10 Drug(s)
Drug(s) Metabolized By Cytochrome P450 2E1 (CYP2E1)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Folic Acid DMEMBJC Colorectal carcinoma Approved [69]
Cisplatin DMRHGI9 Adenocarcinoma 2D40 Approved [70]
Tamoxifen DMLB0EZ Breast cancer 2C60-2C65 Approved [71]
Acetaminophen DMUIE76 Allergic rhinitis CA08.0 Approved [72]
Etoposide DMNH3PG Acute myelogenous leukaemia 2A41 Approved [73]
Oxaliplatin DMQNWRD Adenocarcinoma 2D40 Approved [48]
Verapamil DMA7PEW Angina pectoris BA40 Approved [74]
Propofol DMB4OLE Anaesthesia 9A78.6 Approved [75]
Ethanol DMDRQZU Chronic pain MG30 Approved [76]
Nicotine DMWX5CO Lung cancer 2C25.0 Approved [77]
⏷ Show the Full List of 10 Drug(s)
Drug(s) Metabolized By Cytochrome P450 2C9 (CYP2C9)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Progesterone DMUY35B Amenorrhea GA20.0 Approved [78]
Tamoxifen DMLB0EZ Breast cancer 2C60-2C65 Approved [79]
Estradiol DMUNTE3 Acne vulgaris ED80 Approved [11]
Acetaminophen DMUIE76 Allergic rhinitis CA08.0 Approved [74]
Imatinib DM7RJXL Acute lymphoblastic leukaemia 2A85 Approved [80]
Zidovudine DM4KI7O Human immunodeficiency virus infection 1C62 Approved [74]
Verapamil DMA7PEW Angina pectoris BA40 Approved [81]
Diclofenac DMPIHLS Chronic renal failure GB61.Z Approved [82]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [83]
Pravastatin DM6A0X7 Adult acute monocytic leukemia Approved [84]
⏷ Show the Full List of 10 Drug(s)
Drug(s) Metabolized By Cytochrome P450 2B6 (CYP2B6)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Tamoxifen DMLB0EZ Breast cancer 2C60-2C65 Approved [85]
Verapamil DMA7PEW Angina pectoris BA40 Approved [74]
Diclofenac DMPIHLS Chronic renal failure GB61.Z Approved [86]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [87]
Irinotecan DMP6SC2 Adenocarcinoma 2D40 Approved [88]
Propofol DMB4OLE Anaesthesia 9A78.6 Approved [89]
Nicotine DMWX5CO Lung cancer 2C25.0 Approved [90]
Phenytoin DMNOKBV Epilepsy 8A60-8A68 Approved [91]
Amitriptyline DMK7F9S Depression 6A70-6A7Z Approved [92]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [74]
⏷ Show the Full List of 10 Drug(s)
Drug(s) Metabolized By Cytochrome P450 1B1 (CYP1B1)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Progesterone DMUY35B Amenorrhea GA20.0 Approved [93]
Estradiol DMUNTE3 Acne vulgaris ED80 Approved [53]
Oxaliplatin DMQNWRD Adenocarcinoma 2D40 Approved [48]
Erythromycin DM4K7GQ Acne vulgaris ED80 Approved [56]
Rosuvastatin DMMIQ7G Arteriosclerosis BD40 Approved [94]
Vitamin A DMJ2AH4 Night blindness 9D45 Approved [95]
Caffeine DMKBJWP Allergic rhinitis CA08.0 Approved [96]
Melatonin DMKWFBT Depression 6A70-6A7Z Approved [97]
Theophylline DMRJFN9 Bronchitis CA20 Approved [96]
Flutamide DMK0O7U Prostate cancer 2C82.0 Approved [98]
Flutamide DMK0O7U Prostate cancer 2C82.0 Approved [145]
Hydrogen peroxide DM1NG5W Infectious disease 1A00-CA43.1 Approved [154]
Estradiol DMUNTE3 Acne vulgaris ED80 Approved [155]
Progesterone DMUY35B Amenorrhea GA20.0 Approved [156]
Melatonin DMKWFBT Depression 6A70-6A7Z Approved [97]
Vitamin A DMJ2AH4 Night blindness 9D45 Approved [95]
Amodiaquine DME4RA8 Malaria 1F40-1F45 Approved [157]
Daunorubicin DMQUSBT Acute monocytic leukemia Approved [158]
Pantothenic acid DM091H2 Vitamin deficiency 5B55-5B71 Approved [159]
Fulvestrant DM0YZC6 Breast cancer 2C60-2C65 Approved [160]
⏷ Show the Full List of 20 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Clofibrate DMPC1J7 Dysbetalipoproteinemia 5C80.2 Approved [99]
Drug Name Drug ID Indication ICD 11 Highest Status REF
Prasterone DM67VKL Chronic obstructive pulmonary disease CA22 Approved [12]
Drug(s) Metabolized By Farnesol dehydrogenase (AKR1B15)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Estradiol DMUNTE3 Acne vulgaris ED80 Approved [13]
Testosterone cypionate DMC1TEV N. A. N. A. Approved [13]
ANDROSTERONE DMITJAK N. A. N. A. Phase 3 [13]
Nitrobenzaldehyde DM4UHB5 N. A. N. A. Investigative [100]
Drug Name Drug ID Indication ICD 11 Highest Status REF
Prasterone DM67VKL Chronic obstructive pulmonary disease CA22 Approved [12]
Drug Name Drug ID Indication ICD 11 Highest Status REF
Prasterone DM67VKL Chronic obstructive pulmonary disease CA22 Approved [12]
Hydrogen peroxide DM1NG5W Infectious disease 1A00-CA43.1 Approved [118]
Quercetin DM3NC4M Obesity 5B81 Approved [119]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [120]
Arsenic trioxide DM61TA4 Acute lymphoblastic leukaemia 2A85 Approved [121]
Hydroquinone DM6AVR4 Melasma ED60.1 Approved [122]
Plicamycin DM7C8YV Hypercalcaemia 5B91.0 Approved [123]
Testosterone DM7HUNW Hot flushes GA30 Approved [124]
Calcitriol DM8ZVJ7 Congenital alopecia LC30 Approved [125]
Leflunomide DMR8ONJ Arthritis FA20 Approved [126]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Fluoxetine DM3PD2C Bipolar depression Approved [127]
obeticholic acid DM3Q1SM Primary biliary cholangitis DB96.1 Approved [128]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [129]
Isotretinoin DM4QTBN Acne vulgaris ED80 Approved [130]
Testosterone DM7HUNW Hot flushes GA30 Approved [131]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [132]
Temozolomide DMKECZD Adenocarcinoma 2D40 Approved [133]
Cupric Sulfate DMP0NFQ Fungal infection 1F29-1F2F Approved [134]
Cisplatin DMRHGI9 Adenocarcinoma 2D40 Approved [135]
Arsenic DMTL2Y1 N. A. N. A. Approved [136]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Prasterone DM67VKL Chronic obstructive pulmonary disease CA22 Approved [12]
Methotrexate DM2TEOL Anterior urethra cancer Approved [137]
Quercetin DM3NC4M Obesity 5B81 Approved [119]
Arsenic trioxide DM61TA4 Acute lymphoblastic leukaemia 2A85 Approved [138]
Haloperidol DM96SE0 Delirium Approved [139]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [140]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [141]
Ivermectin DMDBX5F Intestinal strongyloidiasis due to nematode parasite 1F6B Approved [142]
Fenofibrate DMFKXDY Coronary atherosclerosis Approved [143]
Cupric Sulfate DMP0NFQ Fungal infection 1F29-1F2F Approved [134]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Flupentixol DM0DJ9O Schizophrenia 6A20 Approved [161]
Sertraline DM0FB1J Coronary heart disease BA80.Z Approved [162]
Crizotinib DM4F29C Non-small-cell lung cancer 2C25.Y Approved [163]
Lamotrigine DM8SXYG Bipolar disorder 6A60 Approved [164]
Cepharanthine DM9Y5JB N. A. N. A. Approved [165]
Itraconazole DMCR1MV Aspergillosis 1F20 Approved [166]
Clozapine DMFC71L Schizophrenia 6A20 Approved [167]
Midostaurin DMI6E0R Acute myeloid leukaemia 2A60 Approved [168]
Trifluoperazine DMKBYWI Anxiety Approved [169]
Olanzapine DMPFN6Y Bipolar depression Approved [167]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Testosterone DM7HUNW Hot flushes GA30 Approved [170]
Progesterone DMUY35B Amenorrhea GA20.0 Approved [170]
Gefitinib DM15F0X Colon adenocarcinoma Approved [171]
Sunitinib DMCBJSR Acute undifferentiated leukemia Approved [117]
Rosuvastatin DMMIQ7G Arteriosclerosis BD40 Approved [172]
Ciprofloxacin XR DM2NLS9 Acute gonococcal cervicitis Approved [173]
Methotrexate DM2TEOL Anterior urethra cancer Approved [174]
Quercetin DM3NC4M Obesity 5B81 Approved [175]
Zidovudine DM4KI7O Human immunodeficiency virus infection 1C62 Approved [176]
Imatinib DM7RJXL Acute lymphoblastic leukaemia 2A85 Approved [177]
⏷ Show the Full List of 10 Drug(s)
Drug(s) Affected By Sulfotransferase 1E1 (SULT1E1)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Meclofenamic acid DM05FXR Ankylosing spondylitis FA92.0 Approved [178]
Sulindac DM2QHZU Acute myelogenous leukaemia 2A41 Approved [178]
Methotrexate DM2TEOL Anterior urethra cancer Approved [179]
Ibuprofen DM8VCBE Dysmenorrhea GA34.3 Approved [178]
Dienestrol DMBSXI0 Atrophic vaginitis GA30.2 Approved [180]
Ethanol DMDRQZU Chronic pain MG30 Approved [181]
Folic Acid DMEMBJC Colorectal carcinoma Approved [182]
Bosentan DMIOGBU Pulmonary arterial hypertension BB01.0 Approved [183]
Sodium lauryl sulfate DMLJ634 Constipation DD91.1 Approved [184]
Diethylstilbestrol DMN3UXQ Gonorrheal vaginitis GA02 Approved [180]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Fulvestrant DM0YZC6 Breast cancer 2C60-2C65 Approved [17]
Hydrogen peroxide DM1NG5W Infectious disease 1A00-CA43.1 Approved [185]
Spironolactone DM2AQ5N Chronic heart failure BD1Z Approved [186]
Colchicine DM2POTE Acute gout flare FA25.0 Approved [187]
Quercetin DM3NC4M Obesity 5B81 Approved [119]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [129]
Cyclophosphamide DM4O2Z7 Advanced cancer 2A00-2F9Z Approved [188]
Arsenic trioxide DM61TA4 Acute lymphoblastic leukaemia 2A85 Approved [189]
Marinol DM70IK5 Anorexia nervosa cachexia 6B80 Approved [190]
Acocantherin DM7JT24 Atrial fibrillation BC81.3 Approved [191]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Fulvestrant DM0YZC6 Breast cancer 2C60-2C65 Approved [17]
Quercetin DM3NC4M Obesity 5B81 Approved [192]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [193]
Aspirin DM672AH Acute coronary syndrome BA41 Approved [194]
Leflunomide DMR8ONJ Arthritis FA20 Approved [126]
Clodronate DM9Y6X7 Hypercalcaemia 5B91.0 Approved [195]
Cidofovir DMA13GD Cytomegalovirus infection 1D82 Approved [195]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [140]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [132]
Ifosfamide DMCT3I8 Adult central nervous system germ cell tumor Approved [195]
⏷ Show the Full List of 10 Drug(s)
Drug(s) Affected By Carbonic anhydrase 12 (CA12)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Acetazolamide DM1AF5U Absence epilepsy Approved [196]
Fulvestrant DM0YZC6 Breast cancer 2C60-2C65 Approved [17]
Hydrogen peroxide DM1NG5W Infectious disease 1A00-CA43.1 Approved [118]
Troglitazone DM3VFPD Diabetic complication 5A2Y Approved [143]
Panobinostat DM58WKG Chronic graft versus host disease Approved [197]
Topiramate DM82Z30 Alcohol dependence 6C40.2 Approved [198]
Calcitriol DM8ZVJ7 Congenital alopecia LC30 Approved [199]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [140]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [200]
Mestranol DMG3F94 Contraception QA21 Approved [17]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Momelotinib DMF98Q0 Myelofibrosis 2A20.2 Approved [201]
Fulvestrant DM0YZC6 Breast cancer 2C60-2C65 Approved [17]
Hydrogen peroxide DM1NG5W Infectious disease 1A00-CA43.1 Approved [202]
Quercetin DM3NC4M Obesity 5B81 Approved [119]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [193]
Paroxetine DM5PVQE Anxiety disorder 6B00-6B0Z Approved [203]
Arsenic trioxide DM61TA4 Acute lymphoblastic leukaemia 2A85 Approved [204]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [140]
Amlodipine DMBDAZV Angina pectoris BA40 Approved [205]
Tofacitinib DMBS370 Rheumatoid arthritis FA20 Approved [206]
⏷ Show the Full List of 10 Drug(s)
Drug(s) Affected By monooxygenase MICAL2 (MICAL2)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Cannabidiol DM0659E Dravet syndrome 8A61.11 Approved [207]
Fulvestrant DM0YZC6 Breast cancer 2C60-2C65 Approved [17]
Hydrogen peroxide DM1NG5W Infectious disease 1A00-CA43.1 Approved [118]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [129]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [208]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [200]
Mestranol DMG3F94 Contraception QA21 Approved [17]
Temozolomide DMKECZD Adenocarcinoma 2D40 Approved [133]
Diethylstilbestrol DMN3UXQ Gonorrheal vaginitis GA02 Approved [17]
Cupric Sulfate DMP0NFQ Fungal infection 1F29-1F2F Approved [134]
⏷ Show the Full List of 10 Drug(s)
Drug(s) Affected By Serine protease 23 (PRSS23)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Fulvestrant DM0YZC6 Breast cancer 2C60-2C65 Approved [209]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [210]
Panobinostat DM58WKG Chronic graft versus host disease Approved [197]
Marinol DM70IK5 Anorexia nervosa cachexia 6B80 Approved [190]
Testosterone DM7HUNW Hot flushes GA30 Approved [124]
Calcitriol DM8ZVJ7 Congenital alopecia LC30 Approved [124]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [140]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [200]
Palbociclib DMD7L94 Breast cancer 2C60-2C65 Approved [211]
Mestranol DMG3F94 Contraception QA21 Approved [17]
⏷ Show the Full List of 10 Drug(s)
Drug(s) Affected By Supervillin (SVIL)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Fulvestrant DM0YZC6 Breast cancer 2C60-2C65 Approved [209]
Quercetin DM3NC4M Obesity 5B81 Approved [212]
Troglitazone DM3VFPD Diabetic complication 5A2Y Approved [213]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [193]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [140]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [214]
Mestranol DMG3F94 Contraception QA21 Approved [17]
Mifepristone DMGZQEF Cushing disease 5A70 Approved [215]
Zoledronate DMIXC7G Adenocarcinoma 2D40 Approved [216]
Diethylstilbestrol DMN3UXQ Gonorrheal vaginitis GA02 Approved [17]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Verapamil DMA7PEW Angina pectoris BA40 Approved [217]
Fulvestrant DM0YZC6 Breast cancer 2C60-2C65 Approved [17]
Sulindac DM2QHZU Acute myelogenous leukaemia 2A41 Approved [217]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [193]
Irbesartan DMTP1DC Diabetic kidney disease GB61.Z Approved [218]
Methazolamide DM7J2TA Glaucoma/ocular hypertension 9C61 Approved [217]
Imatinib DM7RJXL Acute lymphoblastic leukaemia 2A85 Approved [219]
Calcitriol DM8ZVJ7 Congenital alopecia LC30 Approved [220]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [132]
Ivermectin DMDBX5F Intestinal strongyloidiasis due to nematode parasite 1F6B Approved [186]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Fulvestrant DM0YZC6 Breast cancer 2C60-2C65 Approved [17]
Selenium DM25CGV N. A. N. A. Approved [221]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [193]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [140]
Testosterone enanthate DMB6871 N. A. N. A. Approved [222]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [132]
Mestranol DMG3F94 Contraception QA21 Approved [17]
Diethylstilbestrol DMN3UXQ Gonorrheal vaginitis GA02 Approved [17]
Bortezomib DMNO38U Leukemia Approved [223]
Cupric Sulfate DMP0NFQ Fungal infection 1F29-1F2F Approved [134]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Fulvestrant DM0YZC6 Breast cancer 2C60-2C65 Approved [17]
Hydrogen peroxide DM1NG5W Infectious disease 1A00-CA43.1 Approved [118]
Methotrexate DM2TEOL Anterior urethra cancer Approved [224]
Quercetin DM3NC4M Obesity 5B81 Approved [225]
Troglitazone DM3VFPD Diabetic complication 5A2Y Approved [226]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [227]
Hydroquinone DM6AVR4 Melasma ED60.1 Approved [228]
Thalidomide DM70BU5 Adult T-cell leukemia/lymphoma Approved [229]
Testosterone DM7HUNW Hot flushes GA30 Approved [124]
Calcitriol DM8ZVJ7 Congenital alopecia LC30 Approved [227]
⏷ Show the Full List of 10 Drug(s)
Drug(s) Affected By Myb-related protein A (MYBL1)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Fulvestrant DM0YZC6 Breast cancer 2C60-2C65 Approved [17]
Spironolactone DM2AQ5N Chronic heart failure BD1Z Approved [186]
Quercetin DM3NC4M Obesity 5B81 Approved [119]
Panobinostat DM58WKG Chronic graft versus host disease Approved [230]
Arsenic trioxide DM61TA4 Acute lymphoblastic leukaemia 2A85 Approved [231]
Marinol DM70IK5 Anorexia nervosa cachexia 6B80 Approved [232]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [140]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [214]
Ivermectin DMDBX5F Intestinal strongyloidiasis due to nematode parasite 1F6B Approved [186]
Folic Acid DMEMBJC Colorectal carcinoma Approved [182]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Fulvestrant DM0YZC6 Breast cancer 2C60-2C65 Approved [17]
Quercetin DM3NC4M Obesity 5B81 Approved [119]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [210]
Panobinostat DM58WKG Chronic graft versus host disease Approved [197]
Testosterone DM7HUNW Hot flushes GA30 Approved [233]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [140]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [200]
Demecolcine DMCZQGK Solid tumour/cancer 2A00-2F9Z Approved [234]
Ethanol DMDRQZU Chronic pain MG30 Approved [235]
Mestranol DMG3F94 Contraception QA21 Approved [17]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Fulvestrant DM0YZC6 Breast cancer 2C60-2C65 Approved [17]
Hydrogen peroxide DM1NG5W Infectious disease 1A00-CA43.1 Approved [236]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [140]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [237]
Mestranol DMG3F94 Contraception QA21 Approved [17]
Diethylstilbestrol DMN3UXQ Gonorrheal vaginitis GA02 Approved [17]
Melphalan DMOLNHF Hematologic disease 3C0Z Approved [238]
Cupric Sulfate DMP0NFQ Fungal infection 1F29-1F2F Approved [134]
Decitabine DMQL8XJ Acute myelogenous leukaemia 2A41 Approved [239]
Cisplatin DMRHGI9 Adenocarcinoma 2D40 Approved [239]
⏷ Show the Full List of 10 Drug(s)
Drug(s) Affected By Amphiregulin (AREG)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Cannabidiol DM0659E Dravet syndrome 8A61.11 Approved [240]
Fulvestrant DM0YZC6 Breast cancer 2C60-2C65 Approved [241]
Hydrogen peroxide DM1NG5W Infectious disease 1A00-CA43.1 Approved [154]
Methotrexate DM2TEOL Anterior urethra cancer Approved [224]
Deoxycholic acid DM3GYAL Subcutaneous fat disorder EF02 Approved [242]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [243]
Chlorpromazine DMBGZI3 Acute intermittent hepatic porphyria 5C58.11 Approved [244]
Marinol DM70IK5 Anorexia nervosa cachexia 6B80 Approved [190]
Calcitriol DM8ZVJ7 Congenital alopecia LC30 Approved [245]
Exemestane DM9HPW3 Hormonally-responsive breast cancer 2C60-2C65 Approved [246]
⏷ Show the Full List of 10 Drug(s)
Drug(s) Affected By Ephrin-A1 (EFNA1)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Fulvestrant DM0YZC6 Breast cancer 2C60-2C65 Approved [247]
Hydrogen peroxide DM1NG5W Infectious disease 1A00-CA43.1 Approved [118]
Quercetin DM3NC4M Obesity 5B81 Approved [119]
Troglitazone DM3VFPD Diabetic complication 5A2Y Approved [213]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [129]
Panobinostat DM58WKG Chronic graft versus host disease Approved [197]
Arsenic trioxide DM61TA4 Acute lymphoblastic leukaemia 2A85 Approved [248]
Marinol DM70IK5 Anorexia nervosa cachexia 6B80 Approved [190]
Calcitriol DM8ZVJ7 Congenital alopecia LC30 Approved [249]
Leflunomide DMR8ONJ Arthritis FA20 Approved [126]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Beta-carotene DM0RXBT Vitamin deficiency 5B55-5B71 Approved [250]
Fulvestrant DM0YZC6 Breast cancer 2C60-2C65 Approved [17]
Methotrexate DM2TEOL Anterior urethra cancer Approved [137]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [251]
Isotretinoin DM4QTBN Acne vulgaris ED80 Approved [130]
Panobinostat DM58WKG Chronic graft versus host disease Approved [197]
Hydroquinone DM6AVR4 Melasma ED60.1 Approved [252]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [253]
Propofol DMB4OLE Anaesthesia 9A78.6 Approved [254]
Sevoflurane DMC9O43 Anaesthesia 9A78.6 Approved [254]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Fulvestrant DM0YZC6 Breast cancer 2C60-2C65 Approved [17]
Epinephrine DM3KJBC Acute asthma CA23 Approved [255]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [210]
Panobinostat DM58WKG Chronic graft versus host disease Approved [197]
Marinol DM70IK5 Anorexia nervosa cachexia 6B80 Approved [190]
Testosterone DM7HUNW Hot flushes GA30 Approved [131]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [140]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [132]
Mestranol DMG3F94 Contraception QA21 Approved [17]
Zoledronate DMIXC7G Adenocarcinoma 2D40 Approved [216]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Fulvestrant DM0YZC6 Breast cancer 2C60-2C65 Approved [17]
Hydrogen peroxide DM1NG5W Infectious disease 1A00-CA43.1 Approved [256]
Selenium DM25CGV N. A. N. A. Approved [221]
Quercetin DM3NC4M Obesity 5B81 Approved [119]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [257]
Zidovudine DM4KI7O Human immunodeficiency virus infection 1C62 Approved [176]
Isotretinoin DM4QTBN Acne vulgaris ED80 Approved [130]
Panobinostat DM58WKG Chronic graft versus host disease Approved [197]
Isoniazid DM5JVS3 Latent tuberculosis infection Approved [258]
Ibuprofen DM8VCBE Dysmenorrhea GA34.3 Approved [195]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Pantothenic acid DM091H2 Vitamin deficiency 5B55-5B71 Approved [159]
Fulvestrant DM0YZC6 Breast cancer 2C60-2C65 Approved [17]
Hydrogen peroxide DM1NG5W Infectious disease 1A00-CA43.1 Approved [118]
Methimazole DM25FL8 Hyperthyroidism 5A02 Approved [259]
Colchicine DM2POTE Acute gout flare FA25.0 Approved [187]
Methotrexate DM2TEOL Anterior urethra cancer Approved [137]
Quercetin DM3NC4M Obesity 5B81 Approved [119]
Troglitazone DM3VFPD Diabetic complication 5A2Y Approved [213]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [260]
Methylprednisolone DM4BDON Acute adrenal insufficiency Approved [261]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Fulvestrant DM0YZC6 Breast cancer 2C60-2C65 Approved [17]
Hydrogen peroxide DM1NG5W Infectious disease 1A00-CA43.1 Approved [118]
Methotrexate DM2TEOL Anterior urethra cancer Approved [224]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [262]
Panobinostat DM58WKG Chronic graft versus host disease Approved [197]
Testosterone DM7HUNW Hot flushes GA30 Approved [124]
Calcitriol DM8ZVJ7 Congenital alopecia LC30 Approved [124]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [253]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [132]
Folic Acid DMEMBJC Colorectal carcinoma Approved [182]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Fulvestrant DM0YZC6 Breast cancer 2C60-2C65 Approved [209]
Hydrogen peroxide DM1NG5W Infectious disease 1A00-CA43.1 Approved [118]
Sulindac DM2QHZU Acute myelogenous leukaemia 2A41 Approved [263]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [129]
Arsenic trioxide DM61TA4 Acute lymphoblastic leukaemia 2A85 Approved [264]
Marinol DM70IK5 Anorexia nervosa cachexia 6B80 Approved [190]
Testosterone DM7HUNW Hot flushes GA30 Approved [124]
Calcitriol DM8ZVJ7 Congenital alopecia LC30 Approved [124]
Leflunomide DMR8ONJ Arthritis FA20 Approved [126]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [140]
⏷ Show the Full List of 10 Drug(s)
Drug(s) Affected By Cyclin-G2 (CCNG2)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Fulvestrant DM0YZC6 Breast cancer 2C60-2C65 Approved [17]
Quercetin DM3NC4M Obesity 5B81 Approved [119]
Fluoxetine DM3PD2C Bipolar depression Approved [188]
Panobinostat DM58WKG Chronic graft versus host disease Approved [197]
Arsenic trioxide DM61TA4 Acute lymphoblastic leukaemia 2A85 Approved [248]
Calcitriol DM8ZVJ7 Congenital alopecia LC30 Approved [220]
Clodronate DM9Y6X7 Hypercalcaemia 5B91.0 Approved [195]
Cidofovir DMA13GD Cytomegalovirus infection 1D82 Approved [195]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [208]
Lindane DMB8CNL Infestations of lice and scabies 1G00.Z Approved [188]
⏷ Show the Full List of 10 Drug(s)
Drug(s) Affected By Kynureninase (KYNU)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Fulvestrant DM0YZC6 Breast cancer 2C60-2C65 Approved [17]
Hydrogen peroxide DM1NG5W Infectious disease 1A00-CA43.1 Approved [236]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [120]
Arsenic trioxide DM61TA4 Acute lymphoblastic leukaemia 2A85 Approved [265]
Marinol DM70IK5 Anorexia nervosa cachexia 6B80 Approved [190]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [140]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [132]
Demecolcine DMCZQGK Solid tumour/cancer 2A00-2F9Z Approved [234]
Ivermectin DMDBX5F Intestinal strongyloidiasis due to nematode parasite 1F6B Approved [142]
Mestranol DMG3F94 Contraception QA21 Approved [17]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Fulvestrant DM0YZC6 Breast cancer 2C60-2C65 Approved [17]
Quercetin DM3NC4M Obesity 5B81 Approved [266]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [129]
Calcitriol DM8ZVJ7 Congenital alopecia LC30 Approved [249]
Leflunomide DMR8ONJ Arthritis FA20 Approved [126]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [140]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [132]
Mestranol DMG3F94 Contraception QA21 Approved [17]
Diethylstilbestrol DMN3UXQ Gonorrheal vaginitis GA02 Approved [17]
Melphalan DMOLNHF Hematologic disease 3C0Z Approved [267]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Fulvestrant DM0YZC6 Breast cancer 2C60-2C65 Approved [17]
Hydrogen peroxide DM1NG5W Infectious disease 1A00-CA43.1 Approved [118]
Panobinostat DM58WKG Chronic graft versus host disease Approved [197]
Arsenic trioxide DM61TA4 Acute lymphoblastic leukaemia 2A85 Approved [265]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [200]
Mestranol DMG3F94 Contraception QA21 Approved [17]
Temozolomide DMKECZD Adenocarcinoma 2D40 Approved [133]
Paclitaxel DMLB81S Breast carcinoma Approved [268]
Diethylstilbestrol DMN3UXQ Gonorrheal vaginitis GA02 Approved [17]
Amiodarone DMUTEX3 Tachyarrhythmias BC71 Approved [269]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Fulvestrant DM0YZC6 Breast cancer 2C60-2C65 Approved [17]
Quercetin DM3NC4M Obesity 5B81 Approved [119]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [210]
Panobinostat DM58WKG Chronic graft versus host disease Approved [197]
Marinol DM70IK5 Anorexia nervosa cachexia 6B80 Approved [190]
Testosterone enanthate DMB6871 N. A. N. A. Approved [222]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [132]
Mestranol DMG3F94 Contraception QA21 Approved [17]
Diethylstilbestrol DMN3UXQ Gonorrheal vaginitis GA02 Approved [17]
Cupric Sulfate DMP0NFQ Fungal infection 1F29-1F2F Approved [134]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Fulvestrant DM0YZC6 Breast cancer 2C60-2C65 Approved [17]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [129]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [208]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [132]
Mestranol DMG3F94 Contraception QA21 Approved [17]
Sodium lauryl sulfate DMLJ634 Constipation DD91.1 Approved [184]
Dexamethasone DMMWZET Acute adrenal insufficiency Approved [270]
Diethylstilbestrol DMN3UXQ Gonorrheal vaginitis GA02 Approved [17]
Cupric Sulfate DMP0NFQ Fungal infection 1F29-1F2F Approved [134]
Arsenic DMTL2Y1 N. A. N. A. Approved [271]
⏷ Show the Full List of 10 Drug(s)
Drug(s) Affected By DNA endonuclease RBBP8 (RBBP8)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Fulvestrant DM0YZC6 Breast cancer 2C60-2C65 Approved [17]
Quercetin DM3NC4M Obesity 5B81 Approved [119]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [129]
Testosterone DM7HUNW Hot flushes GA30 Approved [124]
Calcitriol DM8ZVJ7 Congenital alopecia LC30 Approved [124]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [140]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [272]
Demecolcine DMCZQGK Solid tumour/cancer 2A00-2F9Z Approved [234]
Mestranol DMG3F94 Contraception QA21 Approved [17]
Amiodarone DMUTEX3 Tachyarrhythmias BC71 Approved [269]
⏷ Show the Full List of 10 Drug(s)
Drug(s) Affected By Noelin (OLFM1)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Fulvestrant DM0YZC6 Breast cancer 2C60-2C65 Approved [17]
Methotrexate DM2TEOL Anterior urethra cancer Approved [224]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [210]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [273]
Mestranol DMG3F94 Contraception QA21 Approved [17]
Diethylstilbestrol DMN3UXQ Gonorrheal vaginitis GA02 Approved [274]
Arsenic DMTL2Y1 N. A. N. A. Approved [136]
Fluorouracil DMUM7HZ Adenocarcinoma 2D40 Approved [275]
Estradiol DMUNTE3 Acne vulgaris ED80 Approved [155]
Progesterone DMUY35B Amenorrhea GA20.0 Approved [156]
⏷ Show the Full List of 10 Drug(s)
Drug(s) Affected By Spermine oxidase (SMOX)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Fulvestrant DM0YZC6 Breast cancer 2C60-2C65 Approved [17]
Selenium DM25CGV N. A. N. A. Approved [221]
Quercetin DM3NC4M Obesity 5B81 Approved [119]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [276]
Testosterone DM7HUNW Hot flushes GA30 Approved [124]
Calcitriol DM8ZVJ7 Congenital alopecia LC30 Approved [124]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [140]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [132]
Mestranol DMG3F94 Contraception QA21 Approved [17]
Zoledronate DMIXC7G Adenocarcinoma 2D40 Approved [216]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Fulvestrant DM0YZC6 Breast cancer 2C60-2C65 Approved [17]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [193]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [140]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [214]
Mestranol DMG3F94 Contraception QA21 Approved [17]
Niclosamide DMJAGXQ Cestodes infection 1F70-1F76 Approved [277]
Temozolomide DMKECZD Adenocarcinoma 2D40 Approved [133]
Diethylstilbestrol DMN3UXQ Gonorrheal vaginitis GA02 Approved [17]
Cupric Sulfate DMP0NFQ Fungal infection 1F29-1F2F Approved [134]
Decitabine DMQL8XJ Acute myelogenous leukaemia 2A41 Approved [239]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Fulvestrant DM0YZC6 Breast cancer 2C60-2C65 Approved [17]
Marinol DM70IK5 Anorexia nervosa cachexia 6B80 Approved [190]
Testosterone DM7HUNW Hot flushes GA30 Approved [131]
Leflunomide DMR8ONJ Arthritis FA20 Approved [126]
Mestranol DMG3F94 Contraception QA21 Approved [17]
Diethylstilbestrol DMN3UXQ Gonorrheal vaginitis GA02 Approved [17]
Decitabine DMQL8XJ Acute myelogenous leukaemia 2A41 Approved [278]
Cisplatin DMRHGI9 Adenocarcinoma 2D40 Approved [239]
Estradiol DMUNTE3 Acne vulgaris ED80 Approved [279]
Urethane DM7NSI0 N. A. N. A. Phase 4 [280]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Fulvestrant DM0YZC6 Breast cancer 2C60-2C65 Approved [17]
Hydrogen peroxide DM1NG5W Infectious disease 1A00-CA43.1 Approved [118]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [129]
Arsenic trioxide DM61TA4 Acute lymphoblastic leukaemia 2A85 Approved [281]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [208]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [132]
Ivermectin DMDBX5F Intestinal strongyloidiasis due to nematode parasite 1F6B Approved [142]
Mestranol DMG3F94 Contraception QA21 Approved [17]
Temozolomide DMKECZD Adenocarcinoma 2D40 Approved [133]
Diethylstilbestrol DMN3UXQ Gonorrheal vaginitis GA02 Approved [17]
⏷ Show the Full List of 10 Drug(s)
Drug(s) Affected By Estrogen receptor (ESR1)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Estradiol DMUNTE3 Acne vulgaris ED80 Approved [282]
Fulvestrant DM0YZC6 Breast cancer 2C60-2C65 Approved [283]
Gefitinib DM15F0X Colon adenocarcinoma Approved [284]
Hydrogen peroxide DM1NG5W Infectious disease 1A00-CA43.1 Approved [285]
Lapatinib DM3BH1Y Breast cancer 2C60-2C65 Approved [286]
Liraglutide DM3FXPS Non-insulin dependent diabetes 5A11 Approved [287]
Quercetin DM3NC4M Obesity 5B81 Approved [288]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [289]
Procaine DM4LSNE Anaesthesia 9A78.6 Approved [285]
Arsenic trioxide DM61TA4 Acute lymphoblastic leukaemia 2A85 Approved [290]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Hydrogen peroxide DM1NG5W Infectious disease 1A00-CA43.1 Approved [118]
Ramipril DM2R68E Acute heart failure BD10-BD13 Approved [291]
Methotrexate DM2TEOL Anterior urethra cancer Approved [292]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [293]
Panobinostat DM58WKG Chronic graft versus host disease Approved [197]
Arsenic trioxide DM61TA4 Acute lymphoblastic leukaemia 2A85 Approved [248]
Leflunomide DMR8ONJ Arthritis FA20 Approved [126]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [140]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [132]
Folic Acid DMEMBJC Colorectal carcinoma Approved [294]
⏷ Show the Full List of 10 Drug(s)
Drug(s) Affected By Trefoil factor 1 (TFF1)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Fulvestrant DM0YZC6 Breast cancer 2C60-2C65 Approved [295]
Hydrogen peroxide DM1NG5W Infectious disease 1A00-CA43.1 Approved [118]
Spironolactone DM2AQ5N Chronic heart failure BD1Z Approved [296]
Quercetin DM3NC4M Obesity 5B81 Approved [297]
Arsenic trioxide DM61TA4 Acute lymphoblastic leukaemia 2A85 Approved [298]
Reserpine DM6VM38 Hypertension BA00-BA04 Approved [296]
Testosterone DM7HUNW Hot flushes GA30 Approved [299]
Calcitriol DM8ZVJ7 Congenital alopecia LC30 Approved [249]
Exemestane DM9HPW3 Hormonally-responsive breast cancer 2C60-2C65 Approved [246]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [119]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Levonorgestrel DM1DP7T Atypical endometrial hyperplasia Approved [300]
Quercetin DM3NC4M Obesity 5B81 Approved [119]
Fructose DM43AN2 Vomiting MD90 Approved [301]
Oxcarbazepine DM5PU6O Epilepsy 8A60-8A68 Approved [302]
Testosterone DM7HUNW Hot flushes GA30 Approved [303]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [208]
Dienestrol DMBSXI0 Atrophic vaginitis GA30.2 Approved [304]
Hesperetin DMKER83 High blood cholesterol level 5C80.00 Approved [304]
Masoprocol DMMVNZ0 Prostate cancer 2C82.0 Approved [304]
Diethylstilbestrol DMN3UXQ Gonorrheal vaginitis GA02 Approved [304]
⏷ Show the Full List of 10 Drug(s)
Drug(s) Affected By Progesterone receptor (PGR)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Fulvestrant DM0YZC6 Breast cancer 2C60-2C65 Approved [305]
Drospirenone DM1A9W3 Acne vulgaris ED80 Approved [306]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [307]
Tibolone DM78XFG Anabolic metabolism 5C50-5C8Z Approved [308]
Testosterone DM7HUNW Hot flushes GA30 Approved [309]
Exemestane DM9HPW3 Hormonally-responsive breast cancer 2C60-2C65 Approved [246]
Goserelin DMAT8CG Breast cancer 2C60-2C65 Approved [310]
Lindane DMB8CNL Infestations of lice and scabies 1G00.Z Approved [311]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [132]
Docetaxel DMDI269 Advanced cancer 2A00-2F9Z Approved [312]
⏷ Show the Full List of 10 Drug(s)
Drug(s) Affected By Gamma-enolase (ENO2)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Selenium DM25CGV N. A. N. A. Approved [221]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [313]
Aluminium DM6ECN9 Hyperhidrosis EE00 Approved [314]
LY2835219 DM93VBZ Breast cancer 2C60-2C65 Approved [315]
Leflunomide DMR8ONJ Arthritis FA20 Approved [126]
Clodronate DM9Y6X7 Hypercalcaemia 5B91.0 Approved [195]
Cidofovir DMA13GD Cytomegalovirus infection 1D82 Approved [195]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [253]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [200]
Ifosfamide DMCT3I8 Adult central nervous system germ cell tumor Approved [195]
⏷ Show the Full List of 10 Drug(s)
Drug(s) Affected By Protein S100-P (S100P)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Cannabidiol DM0659E Dravet syndrome 8A61.11 Approved [240]
Mechlorethamine DM0CVXA Chronic myelogenous leukaemia 2A20.0 Approved [316]
Hydrogen peroxide DM1NG5W Infectious disease 1A00-CA43.1 Approved [154]
Quercetin DM3NC4M Obesity 5B81 Approved [192]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [120]
Cyclophosphamide DM4O2Z7 Advanced cancer 2A00-2F9Z Approved [317]
Hydroquinone DM6AVR4 Melasma ED60.1 Approved [122]
Adenosine triphosphate DM79F6G Malnutrition 5B50-5B71 Approved [318]
Testosterone DM7HUNW Hot flushes GA30 Approved [124]
Calcitriol DM8ZVJ7 Congenital alopecia LC30 Approved [124]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Cisplatin DMRHGI9 Adenocarcinoma 2D40 Approved [319]
Progesterone DMUY35B Amenorrhea GA20.0 Approved [320]
Cannabidiol DM0659E Dravet syndrome 8A61.11 Approved [321]
Sertraline DM0FB1J Coronary heart disease BA80.Z Approved [322]
Beta-carotene DM0RXBT Vitamin deficiency 5B55-5B71 Approved [323]
Fulvestrant DM0YZC6 Breast cancer 2C60-2C65 Approved [324]
Secobarbital DM14RF5 Epilepsy 8A60-8A68 Approved [325]
Gefitinib DM15F0X Colon adenocarcinoma Approved [326]
Fexofenadine DM17ONX Allergic rhinitis CA08.0 Approved [327]
Hydrogen peroxide DM1NG5W Infectious disease 1A00-CA43.1 Approved [328]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Ethanol DMDRQZU Chronic pain MG30 Approved [329]
Progesterone DMUY35B Amenorrhea GA20.0 Approved [320]
Carvedilol DMHTEAO Chronic heart failure BD1Z Approved [330]
Paclitaxel DMLB81S Breast carcinoma Approved [331]
Etoposide DMNH3PG Acute myelogenous leukaemia 2A41 Approved [332]
Cisplatin DMRHGI9 Adenocarcinoma 2D40 Approved [319]
Urokinase DM0GOUD Myocardial infarction BA41-BA43 Approved [117]
Cannabidiol DM0659E Dravet syndrome 8A61.11 Approved [333]
Sertraline DM0FB1J Coronary heart disease BA80.Z Approved [322]
Beta-carotene DM0RXBT Vitamin deficiency 5B55-5B71 Approved [323]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Capivasertib DM9SKW8 Breast cancer 2C60-2C65 Approved [334]
Nicotine DMWX5CO Lung cancer 2C25.0 Approved [335]
Cannabidiol DM0659E Dravet syndrome 8A61.11 Approved [336]
Beta-carotene DM0RXBT Vitamin deficiency 5B55-5B71 Approved [337]
Gefitinib DM15F0X Colon adenocarcinoma Approved [338]
Hydrogen peroxide DM1NG5W Infectious disease 1A00-CA43.1 Approved [339]
Imiquimod DM1TMA3 Alopecia areata ED70.2 Approved [340]
Selenium DM25CGV N. A. N. A. Approved [221]
Methimazole DM25FL8 Hyperthyroidism 5A02 Approved [341]
Ribavirin DMEYLH9 Hepatitis C virus infection 1E51.1 Approved [342]
⏷ Show the Full List of 10 Drug(s)
Drug(s) Affected By Caspase-3 (CASP3)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Sevoflurane DMC9O43 Anaesthesia 9A78.6 Approved [343]
Arsenic trioxide DM61TA4 Acute lymphoblastic leukaemia 2A85 Approved [344]
Lovastatin DM9OZWQ Arteriosclerosis BD40 Approved [345]
Cidofovir DMA13GD Cytomegalovirus infection 1D82 Approved [346]
Docetaxel DMDI269 Advanced cancer 2A00-2F9Z Approved [347]
Etoposide DMNH3PG Acute myelogenous leukaemia 2A41 Approved [348]
Cisplatin DMRHGI9 Adenocarcinoma 2D40 Approved [349]
Mannitol DMSCDY9 Bronchiectasis CA24 Approved [350]
Doxorubicin DMVP5YE Acute myelogenous leukaemia 2A41 Approved [351]
Aprepitant DM053KT Depression 6A70-6A7Z Approved [352]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Hydrogen peroxide DM1NG5W Infectious disease 1A00-CA43.1 Approved [256]
Selenium DM25CGV N. A. N. A. Approved [221]
Etretinate DM2CZFA Keratosis ED56 Approved [353]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [129]
Hydroquinone DM6AVR4 Melasma ED60.1 Approved [354]
Marinol DM70IK5 Anorexia nervosa cachexia 6B80 Approved [355]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [200]
Ivermectin DMDBX5F Intestinal strongyloidiasis due to nematode parasite 1F6B Approved [142]
Ampicillin DMHWE7P Acute epiglottitis Approved [119]
Zoledronate DMIXC7G Adenocarcinoma 2D40 Approved [356]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Hydrogen peroxide DM1NG5W Infectious disease 1A00-CA43.1 Approved [118]
Quercetin DM3NC4M Obesity 5B81 Approved [119]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [193]
Ethacrynic acid DM60QMR Edema MG29 Approved [357]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [253]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [132]
Ivermectin DMDBX5F Intestinal strongyloidiasis due to nematode parasite 1F6B Approved [142]
Furosemide DMMQ8ZG Congestive heart failure BD10 Approved [357]
Diethylstilbestrol DMN3UXQ Gonorrheal vaginitis GA02 Approved [358]
Estriol DMOEM2I Hormone deficiency 5A61.1 Approved [358]
⏷ Show the Full List of 10 Drug(s)
Drug(s) Affected By Caspase-7 (CASP7)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Cannabidiol DM0659E Dravet syndrome 8A61.11 Approved [359]
Sertraline DM0FB1J Coronary heart disease BA80.Z Approved [360]
Hydrogen peroxide DM1NG5W Infectious disease 1A00-CA43.1 Approved [361]
Nitric Oxide DM1RBYG Hypertension BA00-BA04 Approved [362]
Spironolactone DM2AQ5N Chronic heart failure BD1Z Approved [363]
Imipramine DM2NUH3 Depression 6A70-6A7Z Approved [363]
Methotrexate DM2TEOL Anterior urethra cancer Approved [292]
Dactinomycin DM2YGNW Adult kidney Wilms tumor Approved [364]
Simvastatin DM30SGU Arteriosclerosis BD40 Approved [365]
Lapatinib DM3BH1Y Breast cancer 2C60-2C65 Approved [366]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Fulvestrant DM0YZC6 Breast cancer 2C60-2C65 Approved [17]
Quercetin DM3NC4M Obesity 5B81 Approved [119]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [276]
Isotretinoin DM4QTBN Acne vulgaris ED80 Approved [130]
Arsenic trioxide DM61TA4 Acute lymphoblastic leukaemia 2A85 Approved [264]
Hydroquinone DM6AVR4 Melasma ED60.1 Approved [122]
Marinol DM70IK5 Anorexia nervosa cachexia 6B80 Approved [190]
Calcitriol DM8ZVJ7 Congenital alopecia LC30 Approved [220]
Leflunomide DMR8ONJ Arthritis FA20 Approved [126]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [367]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Selenium DM25CGV N. A. N. A. Approved [368]
Quercetin DM3NC4M Obesity 5B81 Approved [119]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [140]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [132]
Ivermectin DMDBX5F Intestinal strongyloidiasis due to nematode parasite 1F6B Approved [142]
Temozolomide DMKECZD Adenocarcinoma 2D40 Approved [133]
Dexamethasone DMMWZET Acute adrenal insufficiency Approved [270]
Diethylstilbestrol DMN3UXQ Gonorrheal vaginitis GA02 Approved [358]
Estriol DMOEM2I Hormone deficiency 5A61.1 Approved [358]
Acetaminophen DMUIE76 Allergic rhinitis CA08.0 Approved [369]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Simvastatin DM30SGU Arteriosclerosis BD40 Approved [370]
Quercetin DM3NC4M Obesity 5B81 Approved [371]
Troglitazone DM3VFPD Diabetic complication 5A2Y Approved [372]
Artemether DM48QOT Malaria 1F40-1F45 Approved [373]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [374]
Nefazodone DM4ZS8M Major depressive disorder 6A70.3 Approved [375]
Rifampicin DM5DSFZ Non-insulin dependent diabetes 5A11 Approved [376]
Leflunomide DMR8ONJ Arthritis FA20 Approved [377]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [140]
Lindane DMB8CNL Infestations of lice and scabies 1G00.Z Approved [378]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Fulvestrant DM0YZC6 Breast cancer 2C60-2C65 Approved [17]
Hydrogen peroxide DM1NG5W Infectious disease 1A00-CA43.1 Approved [118]
Isotretinoin DM4QTBN Acne vulgaris ED80 Approved [130]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [272]
Mestranol DMG3F94 Contraception QA21 Approved [17]
Zoledronate DMIXC7G Adenocarcinoma 2D40 Approved [216]
Diethylstilbestrol DMN3UXQ Gonorrheal vaginitis GA02 Approved [379]
Ethinyl Estradiol DMODJ40 Acne vulgaris ED80 Approved [379]
Estriol DMOEM2I Hormone deficiency 5A61.1 Approved [379]
Cupric Sulfate DMP0NFQ Fungal infection 1F29-1F2F Approved [134]
⏷ Show the Full List of 10 Drug(s)
Drug(s) Affected By Estrogen receptor beta (ESR2)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Fulvestrant DM0YZC6 Breast cancer 2C60-2C65 Approved [380]
Gefitinib DM15F0X Colon adenocarcinoma Approved [381]
Quercetin DM3NC4M Obesity 5B81 Approved [382]
Tibolone DM78XFG Anabolic metabolism 5C50-5C8Z Approved [383]
Testosterone DM7HUNW Hot flushes GA30 Approved [384]
Lindane DMB8CNL Infestations of lice and scabies 1G00.Z Approved [385]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [386]
Mestranol DMG3F94 Contraception QA21 Approved [387]
Flutamide DMK0O7U Prostate cancer 2C82.0 Approved [388]
Paclitaxel DMLB81S Breast carcinoma Approved [319]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Cannabidiol DM0659E Dravet syndrome 8A61.11 Approved [389]
Fexofenadine DM17ONX Allergic rhinitis CA08.0 Approved [390]
Hydrogen peroxide DM1NG5W Infectious disease 1A00-CA43.1 Approved [236]
Lumiracoxib DM1S4AG Chronic renal failure GB61.Z Approved [390]
Clavulanate DM2FGRT Bacteremia 1A73 Approved [390]
Methotrexate DM2TEOL Anterior urethra cancer Approved [261]
Dactinomycin DM2YGNW Adult kidney Wilms tumor Approved [391]
Quercetin DM3NC4M Obesity 5B81 Approved [119]
Fluoxetine DM3PD2C Bipolar depression Approved [188]
Troglitazone DM3VFPD Diabetic complication 5A2Y Approved [390]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Fulvestrant DM0YZC6 Breast cancer 2C60-2C65 Approved [380]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [392]
Marinol DM70IK5 Anorexia nervosa cachexia 6B80 Approved [393]
Leflunomide DMR8ONJ Arthritis FA20 Approved [126]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [140]
Testosterone enanthate DMB6871 N. A. N. A. Approved [222]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [367]
Temozolomide DMKECZD Adenocarcinoma 2D40 Approved [133]
Bortezomib DMNO38U Leukemia Approved [223]
Diclofenac DMPIHLS Chronic renal failure GB61.Z Approved [394]
⏷ Show the Full List of 10 Drug(s)
Drug(s) Affected By Sulfotransferase 2A1 (SULT2A1)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Hydrogen peroxide DM1NG5W Infectious disease 1A00-CA43.1 Approved [202]
Methotrexate DM2TEOL Anterior urethra cancer Approved [224]
Quercetin DM3NC4M Obesity 5B81 Approved [119]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [395]
Isotretinoin DM4QTBN Acne vulgaris ED80 Approved [395]
Nefazodone DM4ZS8M Major depressive disorder 6A70.3 Approved [375]
Leflunomide DMR8ONJ Arthritis FA20 Approved [126]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [140]
Lindane DMB8CNL Infestations of lice and scabies 1G00.Z Approved [396]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [397]
⏷ Show the Full List of 10 Drug(s)
Drug(s) Affected By Sulfotransferase 1A1 (SULT1A1)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Acetaminophen DMUIE76 Allergic rhinitis CA08.0 Approved [369]
Liothyronine DM6IR3P Congenital hypothyroidism Approved [398]
Minoxidil DMA2Z4F Alopecia ED70 Approved [399]
Benzyl alcohol DMBVYDI Head and body lice 1G00.0 Approved [400]
Estradiol DMUNTE3 Acne vulgaris ED80 Approved [399]
Meclofenamic acid DM05FXR Ankylosing spondylitis FA92.0 Approved [178]
Hydrogen peroxide DM1NG5W Infectious disease 1A00-CA43.1 Approved [401]
Methotrexate DM2TEOL Anterior urethra cancer Approved [179]
Quercetin DM3NC4M Obesity 5B81 Approved [119]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [193]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Prasterone DM67VKL Chronic obstructive pulmonary disease CA22 Approved [12]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [129]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [132]
Metyrapone DMI7FVQ Cushing disease 5A70 Approved [402]
Alitretinoin DMME8LH Kaposi sarcoma 2B57 Approved [403]
Diethylstilbestrol DMN3UXQ Gonorrheal vaginitis GA02 Approved [404]
Dutasteride DMQ4TJK Benign prostatic hyperplasia GA90 Approved [405]
Acetaminophen DMUIE76 Allergic rhinitis CA08.0 Approved [406]
Estradiol DMUNTE3 Acne vulgaris ED80 Approved [404]
Nicotine DMWX5CO Lung cancer 2C25.0 Approved [407]
⏷ Show the Full List of 10 Drug(s)
Drug(s) Affected By Sulfotransferase 4A1 (SULT4A1)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Arsenic DMTL2Y1 N. A. N. A. Approved [408]
Triclosan DMZUR4N Malaria 1F40-1F45 Approved [409]
Liothyronine DM6IR3P Congenital hypothyroidism Approved [410]
Resveratrol DM3RWXL Giant cell arteritis 4A44.2 Phase 3 [411]
Benzo(a)pyrene DMN7J43 N. A. N. A. Phase 1 [412]
PMID28460551-Compound-2 DM4DOUB N. A. N. A. Patented [413]
Trichostatin A DM9C8NX Solid tumour/cancer 2A00-2F9Z Investigative [367]
Mononitrophenol DM4QO9G N. A. N. A. Investigative [410]
L-thyroxine DM83HWL N. A. N. A. Investigative [410]
⏷ Show the Full List of 9 Drug(s)
Drug(s) Affected By Sulfotransferase 1A3 (SULT1A4)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Acetaminophen DMUIE76 Allergic rhinitis CA08.0 Approved [369]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [414]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [132]
Ethanol DMDRQZU Chronic pain MG30 Approved [181]
Amiodarone DMUTEX3 Tachyarrhythmias BC71 Approved [269]
Irinotecan DMP6SC2 Adenocarcinoma 2D40 Approved [415]
Vitamin C DMXJ7O8 Adenocarcinoma 2D40 Approved [416]
Benzyl alcohol DMBVYDI Head and body lice 1G00.0 Approved [400]
Epinephrine DM3KJBC Acute asthma CA23 Approved [399]
Troglitazone DM3VFPD Diabetic complication 5A2Y Approved [399]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Dantrolene DM1D8XY Hyperthermia MG26 Approved [417]
Quercetin DM3NC4M Obesity 5B81 Approved [418]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [395]
Panobinostat DM58WKG Chronic graft versus host disease Approved [197]
Arsenic trioxide DM61TA4 Acute lymphoblastic leukaemia 2A85 Approved [281]
Aspirin DM672AH Acute coronary syndrome BA41 Approved [419]
Testosterone DM7HUNW Hot flushes GA30 Approved [420]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [367]
Folic Acid DMEMBJC Colorectal carcinoma Approved [421]
Dasatinib DMJV2EK Blast phase chronic myelogenous leukemia, BCR-ABL1 positive Approved [422]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Epinephrine DM3KJBC Acute asthma CA23 Approved [423]
Dobutamine DMD1B8Z Heart failure BD10-BD13 Approved [423]
Dopamine DMPGUCF Acromegaly 5A60.0 Approved [423]
Modafinil DMYILBE Malignant glioma 2A00.0 Approved [424]
Levodopa DMN3E57 Parkinson disease 8A00.0 Approved [423]
Fulvestrant DM0YZC6 Breast cancer 2C60-2C65 Approved [380]
Hydrogen peroxide DM1NG5W Infectious disease 1A00-CA43.1 Approved [256]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [210]
Tolcapone DM8MNVO Parkinson disease 8A00.0 Approved [425]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [132]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Hydrogen peroxide DM1NG5W Infectious disease 1A00-CA43.1 Approved [118]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [276]
Isotretinoin DM4QTBN Acne vulgaris ED80 Approved [426]
Panobinostat DM58WKG Chronic graft versus host disease Approved [197]
Testosterone DM7HUNW Hot flushes GA30 Approved [124]
Calcitriol DM8ZVJ7 Congenital alopecia LC30 Approved [220]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [140]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [132]
Rosiglitazone DMILWZR Chronic kidney disease GB61 Approved [427]
Zoledronate DMIXC7G Adenocarcinoma 2D40 Approved [216]
⏷ Show the Full List of 10 Drug(s)
Drug(s) Affected By Cytochrome P450 3A7 (CYP3A7)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Tretinoin DM49DUI Acne vulgaris ED80 Approved [395]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [140]
Dexamethasone DMMWZET Acute adrenal insufficiency Approved [428]
Phenytoin DMNOKBV Epilepsy 8A60-8A68 Approved [429]
Estradiol DMUNTE3 Acne vulgaris ED80 Approved [430]
Phenobarbital DMXZOCG Cluster headache 8A81.0 Approved [431]
Carbamazepine DMZOLBI Epilepsy 8A60-8A68 Approved [432]
Prasterone DM67VKL Chronic obstructive pulmonary disease CA22 Approved [433]
Imatinib DM7RJXL Acute lymphoblastic leukaemia 2A85 Approved [434]
obeticholic acid DM3Q1SM Primary biliary cholangitis DB96.1 Approved [128]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Doxorubicin DMVP5YE Acute myelogenous leukaemia 2A41 Approved [435]
Meclofenamic acid DM05FXR Ankylosing spondylitis FA92.0 Approved [15]
Diazepam DM08E9O Alcohol withdrawal Approved [436]
Levonorgestrel DM1DP7T Atypical endometrial hyperplasia Approved [437]
Desogestrel DM27U4Y Contraception QA21 Approved [437]
Salicyclic acid DM2F8XZ Acne vulgaris ED80 Approved [15]
Sulindac DM2QHZU Acute myelogenous leukaemia 2A41 Approved [15]
Simvastatin DM30SGU Arteriosclerosis BD40 Approved [438]
Quercetin DM3NC4M Obesity 5B81 Approved [439]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [129]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Sulindac DM2QHZU Acute myelogenous leukaemia 2A41 Approved [440]
Quercetin DM3NC4M Obesity 5B81 Approved [440]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [193]
Isotretinoin DM4QTBN Acne vulgaris ED80 Approved [130]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [140]
Flufenamic Acid DMC8VNH Dysmenorrhea GA34.3 Approved [440]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [132]
Demecolcine DMCZQGK Solid tumour/cancer 2A00-2F9Z Approved [234]
Zoledronate DMIXC7G Adenocarcinoma 2D40 Approved [216]
Temozolomide DMKECZD Adenocarcinoma 2D40 Approved [133]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Quercetin DM3NC4M Obesity 5B81 Approved [119]
Arsenic trioxide DM61TA4 Acute lymphoblastic leukaemia 2A85 Approved [441]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [208]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [132]
Ivermectin DMDBX5F Intestinal strongyloidiasis due to nematode parasite 1F6B Approved [142]
Temozolomide DMKECZD Adenocarcinoma 2D40 Approved [133]
Cupric Sulfate DMP0NFQ Fungal infection 1F29-1F2F Approved [134]
Cisplatin DMRHGI9 Adenocarcinoma 2D40 Approved [135]
Amphotericin B DMTAJQE Acne vulgaris ED80 Approved [442]
Doxorubicin DMVP5YE Acute myelogenous leukaemia 2A41 Approved [435]
⏷ Show the Full List of 10 Drug(s)
Drug(s) Affected By Steryl-sulfatase (STS)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Methotrexate DM2TEOL Anterior urethra cancer Approved [261]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [210]
Methylprednisolone DM4BDON Acute adrenal insufficiency Approved [261]
Tazarotene DM8SMD1 Acne vulgaris ED80 Approved [443]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [140]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [132]
Demecolcine DMCZQGK Solid tumour/cancer 2A00-2F9Z Approved [234]
Danazol DML8KTN Menorrhagia GA20.50 Approved [444]
Alitretinoin DMME8LH Kaposi sarcoma 2B57 Approved [443]
Azathioprine DMMZSXQ Lupus nephritis 4A40.0Y Approved [261]
⏷ Show the Full List of 10 Drug(s)
Drug(s) Affected By Aromatase (CYP19A1)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Letrozole DMH07Y3 Estrogen-receptor positive breast cancer Approved [445]
Cannabidiol DM0659E Dravet syndrome 8A61.11 Approved [446]
Sertraline DM0FB1J Coronary heart disease BA80.Z Approved [447]
Fulvestrant DM0YZC6 Breast cancer 2C60-2C65 Approved [380]
Citalopram DM2G9AE Acute coronary syndrome BA41 Approved [447]
Methotrexate DM2TEOL Anterior urethra cancer Approved [137]
FADROZOLE DM3C5GZ Breast cancer 2C60-2C65 Approved [448]
Bifonazole DM3KN7V Fungal infection 1F29-1F2F Approved [449]
Quercetin DM3NC4M Obesity 5B81 Approved [450]
Fluoxetine DM3PD2C Bipolar depression Approved [447]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Etretinate DM2CZFA Keratosis ED56 Approved [451]
FADROZOLE DM3C5GZ Breast cancer 2C60-2C65 Approved [448]
Troglitazone DM3VFPD Diabetic complication 5A2Y Approved [452]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [453]
Prasterone DM67VKL Chronic obstructive pulmonary disease CA22 Approved [454]
Testosterone DM7HUNW Hot flushes GA30 Approved [454]
Pyruvic acid DM7Q41G Malnutrition 5B50-5B71 Approved [455]
Topiramate DM82Z30 Alcohol dependence 6C40.2 Approved [456]
Lamotrigine DM8SXYG Bipolar disorder 6A60 Approved [456]
ABIRATERONE DM8V75C Prostate cancer 2C82.0 Approved [457]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Lidocaine DML4ZOT Anaesthesia 9A78.6 Approved [117]
Paricalcitol DMYBV3G Hyperparathyroidism 5A51 Approved [117]
Hydrogen peroxide DM1NG5W Infectious disease 1A00-CA43.1 Approved [401]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [293]
Arsenic trioxide DM61TA4 Acute lymphoblastic leukaemia 2A85 Approved [458]
Marinol DM70IK5 Anorexia nervosa cachexia 6B80 Approved [459]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [132]
Isoproterenol DMK7MEY Atrioventricular block Approved [460]
Ethinyl Estradiol DMODJ40 Acne vulgaris ED80 Approved [461]
Decitabine DMQL8XJ Acute myelogenous leukaemia 2A41 Approved [462]
⏷ Show the Full List of 10 Drug(s)

Molecular Interaction Atlas of This Drug

Molecular Interaction Atlas

Drug Therapeutic Target (DTT)
DTT Name DTT ID UniProt ID MOA REF
Estrogen receptor (ESR) TTZAYWL ESR1_HUMAN Agonist [3]

Drug Transporter (DTP)
DTP Name DTP ID UniProt ID MOA REF
P-glycoprotein 1 (ABCB1) DTUGYRD MDR1_HUMAN Substrate [4]

Drug-Metabolizing Enzyme (DME)
DME Name DME ID UniProt ID MOA REF
Cytochrome P450 3A4 (CYP3A4) DE4LYSA CP3A4_HUMAN Substrate [5]
Cytochrome P450 2E1 (CYP2E1) DEVDYN7 CP2E1_HUMAN Substrate [6]
Cytochrome P450 2C9 (CYP2C9) DE5IED8 CP2C9_HUMAN Substrate [7]
Cytochrome P450 1A1 (CYP1A1) DE6OQ3W CP1A1_HUMAN Substrate [8]
Cytochrome P450 1A2 (CYP1A2) DEJGDUW CP1A2_HUMAN Substrate [9]
Cytochrome P450 3A5 (CYP3A5) DEIBDNY CP3A5_HUMAN Substrate [10]
Cytochrome P450 1B1 (CYP1B1) DE9QHP6 CP1B1_HUMAN Substrate [8]
Cytochrome P450 2B6 (CYP2B6) DEPKLMQ CP2B6_HUMAN Substrate [11]
Estradiol 17-beta-dehydrogenase 2 (HSD17B2) DEBMFZ8 DHB2_HUMAN Substrate [12]
Keto-steroid reductase (HSD17B7) DEDMWFX DHB7_HUMAN Substrate [12]
Farnesol dehydrogenase (AKR1B15) DER0XCH AK1BF_HUMAN Substrate [13]
Lauric acid omega-hydroxylase (CYP4A11) DE2XQGW CP4AB_HUMAN Substrate [11]
Peroxisomal multifunctional enzyme 2 (HSD17B4) DEJHG19 DHB4_HUMAN Substrate [12]
Ketoacyl-CoA reductase (HSD17B12) DE915QP DHB12_HUMAN Substrate [14]

Drug Off-Target (DOT)
DOT Name DOT ID UniProt ID Interaction REF
17-beta-hydroxysteroid dehydrogenase type 1 (HSD17B1) OT6EBDHM DHB1_HUMAN Biotransformations [12]
17-beta-hydroxysteroid dehydrogenase type 2 (HSD17B2) OT3K7HY5 DHB2_HUMAN Biotransformations [12]
3-keto-steroid reductase/17-beta-hydroxysteroid dehydrogenase 7 (HSD17B7) OTV7VOV3 DHB7_HUMAN Biotransformations [12]
Aldo-keto reductase family 1 member C3 (AKR1C3) OTU2SXBA AK1C3_HUMAN Regulation of Drug Effects [15]
Alkaline phosphatase, placental type (ALPP) OTZU4G9W PPB1_HUMAN Biotransformations [16]
Amphiregulin (AREG) OTJFOR67 AREG_HUMAN Gene/Protein Processing [17]
Aromatase (CYP19A1) OTZ6XF74 CP19A_HUMAN Biotransformations [12]
ATP-dependent translocase ABCB1 (ABCB1) OTEJROBO MDR1_HUMAN Gene/Protein Processing [4]
Broad substrate specificity ATP-binding cassette transporter ABCG2 (ABCG2) OTW8V2V1 ABCG2_HUMAN Gene/Protein Processing [18]
Carbonic anhydrase 12 (CA12) OT6WNFU8 CAH12_HUMAN Gene/Protein Processing [17]

References

1 Estrone FDA Label
2 URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 2818).
3 Reprint of Are all estrogens the same Maturitas. 2008 Sep-Oct;61(1-2):195-201.
4 P-glycoprotein (P-gp/MDR1)-mediated efflux of sex-steroid hormones and modulation of P-gp expression in vitro. Pharm Res. 2004 Jul;21(7):1284-93.
5 Regioselective hydroxylation of steroid hormones by human cytochromes P450. Drug Metab Rev. 2015 May;47(2):89-110.
6 Novel metabolic pathway of estrone and 17beta-estradiol catalyzed by cytochrome P-450. Drug Metab Dispos. 2000 Feb;28(2):110-2.
7 A potential role for the estrogen-metabolizing cytochrome P450 enzymes in human breast carcinogenesis. Breast Cancer Res Treat. 2003 Dec;82(3):191-7.
8 A common CYP1B1 polymorphism is associated with 2-OHE1/16-OHE1 urinary estrone ratio. Clin Chem Lab Med. 2005;43(7):702-6.
9 A transgenic mouse expressing human CYP1A2 in the pancreas. Biochem Pharmacol. 2000 Sep 15;60(6):857-63.
10 16Alpha-hydroxylation of estrone by human cytochrome P4503A4/5. Carcinogenesis. 1998 May;19(5):867-72.
11 Characterization of the oxidative metabolites of 17beta-estradiol and estrone formed by 15 selectively expressed human cytochrome p450 isoforms. Endocrinology. 2003 Aug;144(8):3382-98.
12 Steroid signalling in the ovarian surface epithelium. Trends Endocrinol Metab. 2005 Sep;16(7):327-33.
13 Aldo-keto Reductase 1B15 (AKR1B15): a mitochondrial human aldo-keto reductase with activity toward steroids and 3-keto-acyl-CoA conjugates. J Biol Chem. 2015 Mar 6;290(10):6531-45.
14 Characterization of type 12 17beta-hydroxysteroid dehydrogenase, an isoform of type 3 17beta-hydroxysteroid dehydrogenase responsible for estradiol formation in women. Mol Endocrinol. 2006 Feb;20(2):437-43.
15 Type 5 17beta-hydroxysteroid dehydrogenase/prostaglandin F synthase (AKR1C3): role in breast cancer and inhibition by non-steroidal anti-inflammatory drug analogs. Chem Biol Interact. 2009 Mar 16;178(1-3):221-7.
16 The in vitro enzymic labilities of chemically distinct phosphomonoester prodrugs. Pharm Res. 1992 Apr;9(4):497-503. doi: 10.1023/a:1015840329786.
17 Moving toward integrating gene expression profiling into high-throughput testing: a gene expression biomarker accurately predicts estrogen receptor alpha modulation in a microarray compendium. Toxicol Sci. 2016 May;151(1):88-103.
18 Effects of sex hormones on regulation of ABCG2 expression in the placental cell line BeWo. J Pharm Pharm Sci. 2006;9(1):133-9.
19 Modulators of vascular sex hormone receptors and their effects in estrogen-deficiency states associated with menopause. Recent Pat Cardiovasc Drug Discov. 2008 Nov;3(3):165-86.
20 Drugs@FDA. U.S. Food and Drug Administration. U.S. Department of Health & Human Services.
21 17alpha-Ethinylestradiol hinders nucleotide excision repair in zebrafish liver cells. Aquat Toxicol. 2009 Dec 13;95(4):273-8.
22 URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Target id: 620).
23 Clinical pipeline report, company report or official report of Shionogi (2011).
24 Effect of selective estrogen receptor modulators on cell proliferation and estrogen receptor activities in normal human prostate stromal and epithe... Prostate Cancer Prostatic Dis. 2009;12(4):375-81.
25 Short-term effects of environmentally relevant concentrations of EDC mixtures on Mytilus galloprovincialis digestive gland. Aquat Toxicol. 2008 May 30;87(4):272-9.
26 Human intestinal transporter database: QSAR modeling and virtual profiling of drug uptake, efflux and interactions. Pharm Res. 2013 Apr;30(4):996-1007.
27 MDR1 (ABCB1) G1199A (Ser400Asn) polymorphism alters transepithelial permeability and sensitivity to anticancer agents. Cancer Chemother Pharmacol. 2009 Jun;64(1):183-8.
28 Mammalian drug efflux transporters of the ATP binding cassette (ABC) family in multidrug resistance: A review of the past decade. Cancer Lett. 2016 Jan 1;370(1):153-64.
29 Folate transporter expression decreases in the human placenta throughout pregnancy and in pre-eclampsia. Pregnancy Hypertens. 2012 Apr;2(2):123-31.
30 Comparative studies on in vitro methods for evaluating in vivo function of MDR1 P-glycoprotein. Pharm Res. 2001 Dec;18(12):1660-8.
31 Antiestrogens and steroid hormones: substrates of the human P-glycoprotein. Biochem Pharmacol. 1994 Jul 19;48(2):287-92.
32 Association of genetic polymorphisms in the influx transporter SLCO1B3 and the efflux transporter ABCB1 with imatinib pharmacokinetics in patients with chronic myeloid leukemia. Ther Drug Monit. 2011 Apr;33(2):244-50.
33 Expression levels and activation of a PXR variant are directly related to drug resistance in osteosarcoma cell lines. Cancer. 2007 Mar 1;109(5):957-65.
34 Contribution of human hepatic cytochrome P450 isoforms to regioselective hydroxylation of steroid hormones. Xenobiotica. 1998 Jun;28(6):539-47.
35 Comprehensive evaluation of tamoxifen sequential biotransformation by the human cytochrome P450 system in vitro: prominent roles for CYP3A and CYP2D6. J Pharmacol Exp Ther. 2004 Sep;310(3):1062-75.
36 Isoform-specific regulation of cytochromes P450 expression by estradiol and progesterone. Drug Metab Dispos. 2013 Feb;41(2):263-9.
37 Metabolic interactions between acetaminophen (paracetamol) and two flavonoids, luteolin and quercetin, through in-vitro inhibition studies. J Pharm Pharmacol. 2017 Dec;69(12):1762-1772.
38 Potent mechanism-based inhibition of CYP3A4 by imatinib explains its liability to interact with CYP3A4 substrates. Br J Pharmacol. 2012 Apr;165(8):2787-98.
39 Effects of morin on the pharmacokinetics of etoposide in rats. Biopharm Drug Dispos. 2007 Apr;28(3):151-6.
40 The metabolism of zidovudine by human liver microsomes in vitro: formation of 3'-amino-3'-deoxythymidine. Biochem Pharmacol. 1994 Jul 19;48(2):267-76.
41 Substrates, inducers, inhibitors and structure-activity relationships of human Cytochrome P450 2C9 and implications in drug development. Curr Med Chem. 2009;16(27):3480-675.
42 Roles of cytochromes P450 1A2, 2A6, and 2C8 in 5-fluorouracil formation from tegafur, an anticancer prodrug, in human liver microsomes. Drug Metab Dispos. 2000 Dec;28(12):1457-63.
43 Effects of polyunsaturated fatty acids on prostaglandin synthesis and cyclooxygenase-mediated DNA adduct formation by heterocyclic aromatic amines in human adenocarcinoma colon cells. Mol Carcinog. 2004 Jul;40(3):180-8.
44 Endoxifen and other metabolites of tamoxifen inhibit human hydroxysteroid sulfotransferase 2A1 (hSULT2A1). Drug Metab Dispos. 2014 Nov;42(11):1843-50.
45 Cytochrome P450 1A2 (CYP1A2) activity and risk factors for breast cancer: a cross-sectional study. Breast Cancer Res. 2004;6(4):R352-65.
46 PharmGKB summary: pathways of acetaminophen metabolism at the therapeutic versus toxic doses. Pharmacogenet Genomics. 2015 Aug;25(8):416-26.
47 The effect of apigenin on pharmacokinetics of imatinib and its metabolite N-desmethyl imatinib in rats. Biomed Res Int. 2013;2013:789184.
48 The influence of metabolic gene polymorphisms on urinary 1-hydroxypyrene concentrations in Chinese coke oven workers. Sci Total Environ. 2007 Aug 1;381(1-3):38-46.
49 Identification of P450 enzymes involved in metabolism of verapamil in humans. Naunyn Schmiedebergs Arch Pharmacol. 1993 Sep;348(3):332-7.
50 Metabolism and metabolic inhibition of xanthotoxol in human liver microsomes. Evid Based Complement Alternat Med. 2016;2016:5416509.
51 Allelic variants of human cytochrome P450 1A1 (CYP1A1): effect of T461N and I462V substitutions on steroid hydroxylase specificity. Pharmacogenetics. 2000 Aug;10(6):519-30.
52 Metabolism of tamoxifen by recombinant human cytochrome P450 enzymes: formation of the 4-hydroxy, 4'-hydroxy and N-desmethyl metabolites and isomerization of trans-4-hydroxytamoxifen. Drug Metab Dispos. 2002 Aug;30(8):869-74.
53 Cytochrome P450 isoforms catalyze formation of catechol estrogen quinones that react with DNA. Metabolism. 2007 Jul;56(7):887-94.
54 Preferred orientations in the binding of 4'-hydroxyacetanilide (acetaminophen) to cytochrome P450 1A1 and 2B1 isoforms as determined by 13C- and 15N-NMR relaxation studies. J Med Chem. 1994 Mar 18;37(6):860-7.
55 Diclofenac and its derivatives as tools for studying human cytochromes P450 active sites: particular efficiency and regioselectivity of P450 2Cs. Biochemistry. 1999 Oct 26;38(43):14264-70.
56 Cytochromes P450 in crustacea. Comp Biochem Physiol C Pharmacol Toxicol Endocrinol. 1998 Nov;121(1-3):157-72.
57 Disruption of endogenous regulator homeostasis underlies the mechanism of rat CYP1A1 mRNA induction by metyrapone. Biochem J. 1998 Apr 1;331 ( Pt 1):273-81.
58 Pharmacogenomics in drug-metabolizing enzymes catalyzing anticancer drugs for personalized cancer chemotherapy. Curr Drug Metab. 2007 Aug;8(6):554-62.
59 Roles of CYP2A6 and CYP2B6 in nicotine C-oxidation by human liver microsomes. Arch Toxicol. 1999 Mar;73(2):65-70.
60 Drug related genetic polymorphisms affecting adverse reactions to methotrexate, vinblastine, doxorubicin and cisplatin in patients with urothelial cancer. J Urol. 2008 Dec;180(6):2389-95.
61 Human prostate CYP3A5: identification of a unique 5'-untranslated sequence and characterization of purified recombinant protein. Biochem Biophys Res Commun. 1999 Jul 14;260(3):676-81.
62 Polymorphisms in cytochrome P4503A5 (CYP3A5) may be associated with race and tumor characteristics, but not metabolism and side effects of tamoxifen in breast cancer patients. Cancer Lett. 2005 Jan 10;217(1):61-72.
63 Drug Interactions Flockhart Table
64 Induction of hepatic CYP2E1 by a subtoxic dose of acetaminophen in rats: increase in dichloromethane metabolism and carboxyhemoglobin elevation. Drug Metab Dispos. 2007 Oct;35(10):1754-8.
65 Urinary 6 beta-hydroxycortisol excretion in rheumatoid arthritis. Br J Rheumatol. 1997 Jan;36(1):54-8.
66 Clinical pharmacokinetics of imatinib. Clin Pharmacokinet. 2005;44(9):879-94.
67 Kinetics and regulation of cytochrome P450-mediated etoposide metabolism. Drug Metab Dispos. 2004 Sep;32(9):993-1000.
68 Differential mechanism-based inhibition of CYP3A4 and CYP3A5 by verapamil. Drug Metab Dispos. 2005 May;33(5):664-71.
69 Chronic ethanol feeding and folate deficiency activate hepatic endoplasmic reticulum stress pathway in micropigs. Am J Physiol Gastrointest Liver Physiol. 2005 Jul;289(1):G54-63.
70 Cytochrome P450 2E1 null mice provide novel protection against cisplatin-induced nephrotoxicity and apoptosis. Kidney Int. 2003 May;63(5):1687-96.
71 Genotoxicity of tamoxifen, tamoxifen epoxide and toremifene in human lymphoblastoid cells containing human cytochrome P450s. Carcinogenesis. 1994 Jan;15(1):5-9.
72 Acetaminophen induced acute liver failure via oxidative stress and JNK activation: protective role of taurine by the suppression of cytochrome P450 2E1. Free Radic Res. 2010 Mar;44(3):340-55.
73 A study on the metabolism of etoposide and possible interactions with antitumor or supporting agents by human liver microsomes. J Pharmacol Exp Ther. 1998 Sep;286(3):1294-300.
74 Summary of information on human CYP enzymes: human P450 metabolism data. Drug Metab Rev. 2002 Feb-May;34(1-2):83-448.
75 Inhibition of cytochrome P450 2E1 by propofol in human and porcine liver microsomes. Biochem Pharmacol. 2002 Oct 1;64(7):1151-6.
76 CYP2E1 and clinical features in alcoholics. Neuropsychobiology. 2003;47(2):86-9.
77 Effects of nicotine on cytochrome P450 2A6 and 2E1 activities. Br J Clin Pharmacol. 2010 Feb;69(2):152-9.
78 Progesterone and testosterone hydroxylation by cytochromes P450 2C19, 2C9, and 3A4 in human liver microsomes. Arch Biochem Biophys. 1997 Oct 1;346(1):161-9.
79 Tamoxifen inhibits cytochrome P450 2C9 activity in breast cancer patients. J Chemother. 2006 Aug;18(4):421-4.
80 Drug-drug interactions with imatinib: an observational study. Medicine (Baltimore). 2016 Oct;95(40):e5076.
81 Drug interactions with calcium channel blockers: possible involvement of metabolite-intermediate complexation with CYP3A. Drug Metab Dispos. 2000 Feb;28(2):125-30.
82 New insights into the structural features and functional relevance of human cytochrome P450 2C9. Part I. Curr Drug Metab. 2009 Dec;10(10):1075-126.
83 A mechanistic approach to antiepileptic drug interactions. Ann Pharmacother. 1998 May;32(5):554-63.
84 In vitro comparative inhibition profiles of major human drug metabolising cytochrome P450 isozymes (CYP2C9, CYP2D6 and CYP3A4) by HMG-CoA reductase inhibitors. Eur J Clin Pharmacol. 1996;50(3):209-15.
85 Effect of tamoxifen on the enzymatic activity of human cytochrome CYP2B6. J Pharmacol Exp Ther. 2002 Jun;301(3):945-52.
86 Hepatic metabolism of diclofenac: role of human CYP in the minor oxidative pathways. Biochem Pharmacol. 1999 Sep 1;58(5):787-96.
87 Insights into CYP2B6-mediated drug-drug interactions. Acta Pharm Sin B. 2016 Sep;6(5):413-425.
88 Drugs that may have potential CYP2B6 interactions.
89 Involvement of human cytochrome P450 2B6 in the omega- and 4-hydroxylation of the anesthetic agent propofol. Xenobiotica. 2007 Jul;37(7):717-24.
90 Nicotine and 4-(methylnitrosamino)-1-(3-pyridyl)-butanone metabolism by cytochrome P450 2B6. Drug Metab Dispos. 2005 Dec;33(12):1760-4.
91 PharmGKB summary: phenytoin pathway. Pharmacogenet Genomics. 2012 Jun;22(6):466-70.
92 Application of the relative activity factor approach in scaling from heterologously expressed cytochromes p450 to human liver microsomes: studies on amitriptyline as a model substrate. J Pharmacol Exp Ther. 2001 Apr;297(1):326-37.
93 Catalytic properties of polymorphic human cytochrome P450 1B1 variants. Carcinogenesis. 1999 Aug;20(8):1607-13.
94 Pharmacokinetics of rosuvastatin when coadministered with rifampicin in healthy males: a randomized, single-blind, placebo-controlled, crossover study. Clin Ther. 2008 Jul;30(7):1283-9.
95 Metabolism of retinoids and arachidonic acid by human and mouse cytochrome P450 1b1. Drug Metab Dispos. 2004 Aug;32(8):840-7.
96 Oxidation of xenobiotics by recombinant human cytochrome P450 1B1. Drug Metab Dispos. 1997 May;25(5):617-22.
97 Metabolism of melatonin by human cytochromes p450. Drug Metab Dispos. 2005 Apr;33(4):489-94.
98 Human CYP1B1 and anticancer agent metabolism: mechanism for tumor-specific drug inactivation? J Pharmacol Exp Ther. 2001 Feb;296(2):537-41.
99 Regulation of CYP2E1 by ethanol and palmitic acid and CYP4A11 by clofibrate in primary cultures of human hepatocytes. Toxicol Sci. 2004 Jun;79(2):233-41.
100 Functional expression of novel human and murine AKR1B genes. Chem Biol Interact. 2011 May 30;191(1-3):177-84.
101 The relative role of CYP3A4 and CYP3A5 in eplerenone metabolism. Toxicol Lett. 2019 Oct 15;315:9-13.
102 Characterization of the structural determinants required for potent mechanism-based inhibition of human cytochrome P450 1A1 by cannabidiol. Chem Biol Interact. 2014 May 25;215:62-8.
103 Retinoids activate the RXR/SXR-mediated pathway and induce the endogenous CYP3A4 activity in Huh7 human hepatoma cells. Toxicol Sci. 2006 Jul;92(1):51-60.
104 The novel azole R126638 is a selective inhibitor of ergosterol synthesis in Candida albicans, Trichophyton spp., and Microsporum canis. Antimicrob Agents Chemother. 2004 Sep;48(9):3272-8.
105 Application of higher throughput screening (HTS) inhibition assays to evaluate the interaction of antiparasitic drugs with cytochrome P450s. Drug Metab Dispos. 2001 Jan;29(1):30-5.
106 Cetirizine and loratadine-based antihistamines with 5-lipoxygenase inhibitory activity. Bioorg Med Chem Lett. 2004 Nov 15;14(22):5591-4.
107 Mechanism-based inactivation of CYP3A by HIV protease inhibitors. J Pharmacol Exp Ther. 2005 Feb;312(2):583-91.
108 Studies of the toxicological potential of capsinoids, XIII: inhibitory effects of capsaicin and capsinoids on cytochrome P450 3A4 in human liver microsomes. Int J Toxicol. 2010 Mar;29(2 Suppl):22S-6S.
109 Investigation of the effects of axitinib on the pharmacokinetics of loperamide and its main metabolite N-demethylated loperamide in rats by UPLC-MS/MS. Chem Biol Interact. 2019 Sep 1;310:108744. doi: 10.1016/j.cbi.2019.108744. Epub 2019 Jul 9.
110 In vitro inhibition of CYP1A2 by model inhibitors, anti-inflammatory analgesics and female sex steroids: predictability of in vivo interactions. Basic Clin Pharmacol Toxicol. 2008 Aug;103(2):157-65.
111 Effects of capsaicin and dihydrocapsaicin on human and rat liver microsomal CYP450 enzyme activities in vitro and in vivo. J Asian Nat Prod Res. 2012;14(4):382-95.
112 Drug interaction study of flavonoids toward CYP3A4 and their quantitative structure activity relationship (QSAR) analysis for predicting potential effects. Toxicol Lett. 2018 Sep 15;294:27-36.
113 Stiripentol. Expert Opin Investig Drugs. 2005 Jul;14(7):905-11.
114 Inhibition of human cytochrome P450 enzymes by 1,4-dihydropyridine calcium antagonists: prediction of in vivo drug-drug interactions. Eur J Clin Pharmacol. 2000 Feb-Mar;55(11-12):843-52.
115 Mechanism-based inhibition of human liver microsomal cytochrome P450 1A2 by zileuton, a 5-lipoxygenase inhibitor. Drug Metab Dispos. 2003 Nov;31(11):1352-60.
116 Predictive three-dimensional quantitative structure-activity relationship of cytochrome P450 1A2 inhibitors. J Med Chem. 2005 Jun 2;48(11):3808-15.
117 ADReCS-Target: target profiles for aiding drug safety research and application. Nucleic Acids Res. 2018 Jan 4;46(D1):D911-D917. doi: 10.1093/nar/gkx899.
118 Global gene expression analysis reveals differences in cellular responses to hydroxyl- and superoxide anion radical-induced oxidative stress in caco-2 cells. Toxicol Sci. 2010 Apr;114(2):193-203. doi: 10.1093/toxsci/kfp309. Epub 2009 Dec 31.
119 Comparison of phenotypic and transcriptomic effects of false-positive genotoxins, true genotoxins and non-genotoxins using HepG2 cells. Mutagenesis. 2011 Sep;26(5):593-604.
120 Effect of retinoic acid on gene expression in human conjunctival epithelium: secretory phospholipase A2 mediates retinoic acid induction of MUC16. Invest Ophthalmol Vis Sci. 2005 Nov;46(11):4050-61.
121 Classification of heavy-metal toxicity by human DNA microarray analysis. Environ Sci Technol. 2007 May 15;41(10):3769-74.
122 Keratinocyte-derived IL-36gama plays a role in hydroquinone-induced chemical leukoderma through inhibition of melanogenesis in human epidermal melanocytes. Arch Toxicol. 2019 Aug;93(8):2307-2320.
123 SP1 and SP3 mediate progesterone-dependent induction of the 17beta hydroxysteroid dehydrogenase type 2 gene in human endometrium. Biol Reprod. 2006 Oct;75(4):605-14.
124 Effects of 1alpha,25 dihydroxyvitamin D3 and testosterone on miRNA and mRNA expression in LNCaP cells. Mol Cancer. 2011 May 18;10:58.
125 Expression profiling in squamous carcinoma cells reveals pleiotropic effects of vitamin D3 analog EB1089 signaling on cell proliferation, differentiation, and immune system regulation. Mol Endocrinol. 2002 Jun;16(6):1243-56.
126 Endoplasmic reticulum stress and MAPK signaling pathway activation underlie leflunomide-induced toxicity in HepG2 Cells. Toxicology. 2017 Dec 1;392:11-21.
127 Screening autism-associated environmental factors in differentiating human neural progenitors with fractional factorial design-based transcriptomics. Sci Rep. 2023 Jun 29;13(1):10519. doi: 10.1038/s41598-023-37488-0.
128 Pharmacotoxicology of clinically-relevant concentrations of obeticholic acid in an organotypic human hepatocyte system. Toxicol In Vitro. 2017 Mar;39:93-103.
129 Phenotypic characterization of retinoic acid differentiated SH-SY5Y cells by transcriptional profiling. PLoS One. 2013 May 28;8(5):e63862.
130 Temporal changes in gene expression in the skin of patients treated with isotretinoin provide insight into its mechanism of action. Dermatoendocrinol. 2009 May;1(3):177-87.
131 The exosome-like vesicles derived from androgen exposed-prostate stromal cells promote epithelial cells proliferation and epithelial-mesenchymal transition. Toxicol Appl Pharmacol. 2021 Jan 15;411:115384. doi: 10.1016/j.taap.2020.115384. Epub 2020 Dec 25.
132 Integrative omics data analyses of repeated dose toxicity of valproic acid in vitro reveal new mechanisms of steatosis induction. Toxicology. 2018 Jan 15;393:160-170.
133 Temozolomide induces activation of Wnt/-catenin signaling in glioma cells via PI3K/Akt pathway: implications in glioma therapy. Cell Biol Toxicol. 2020 Jun;36(3):273-278. doi: 10.1007/s10565-019-09502-7. Epub 2019 Nov 22.
134 Physiological and toxicological transcriptome changes in HepG2 cells exposed to copper. Physiol Genomics. 2009 Aug 7;38(3):386-401.
135 Activation of AIFM2 enhances apoptosis of human lung cancer cells undergoing toxicological stress. Toxicol Lett. 2016 Sep 6;258:227-236.
136 Prenatal arsenic exposure and the epigenome: identifying sites of 5-methylcytosine alterations that predict functional changes in gene expression in newborn cord blood and subsequent birth outcomes. Toxicol Sci. 2015 Jan;143(1):97-106. doi: 10.1093/toxsci/kfu210. Epub 2014 Oct 10.
137 The contribution of methotrexate exposure and host factors on transcriptional variance in human liver. Toxicol Sci. 2007 Jun;97(2):582-94.
138 Proteomics-based identification of differentially abundant proteins from human keratinocytes exposed to arsenic trioxide. J Proteomics Bioinform. 2014 Jul;7(7):166-178.
139 Cannabidiol Displays Proteomic Similarities to Antipsychotics in Cuprizone-Exposed Human Oligodendrocytic Cell Line MO3.13. Front Mol Neurosci. 2021 May 28;14:673144. doi: 10.3389/fnmol.2021.673144. eCollection 2021.
140 Comparison of HepG2 and HepaRG by whole-genome gene expression analysis for the purpose of chemical hazard identification. Toxicol Sci. 2010 May;115(1):66-79.
141 Gene Expression Regulation and Pathway Analysis After Valproic Acid and Carbamazepine Exposure in a Human Embryonic Stem Cell-Based Neurodevelopmental Toxicity Assay. Toxicol Sci. 2015 Aug;146(2):311-20. doi: 10.1093/toxsci/kfv094. Epub 2015 May 15.
142 Quantitative proteomics reveals a broad-spectrum antiviral property of ivermectin, benefiting for COVID-19 treatment. J Cell Physiol. 2021 Apr;236(4):2959-2975. doi: 10.1002/jcp.30055. Epub 2020 Sep 22.
143 Transcriptomic analysis of untreated and drug-treated differentiated HepaRG cells over a 2-week period. Toxicol In Vitro. 2015 Dec 25;30(1 Pt A):27-35.
144 Cytochrome P450 1A1/2 induction by antiparasitic drugs: dose-dependent increase in ethoxyresorufin O-deethylase activity and mRNA caused by quinine, primaquine and albendazole in HepG2 cells. Eur J Clin Pharmacol. 2002 Nov;58(8):537-42.
145 Association of CYP1A1 and CYP1B1 inhibition in in vitro assays with drug-induced liver injury. J Toxicol Sci. 2021;46(4):167-176. doi: 10.2131/jts.46.167.
146 Anti-androgenic effect of 6-formylindolo[3,2-b]carbazole (FICZ) in LNCaP cells is mediated by the aryl hydrocarbon-androgen receptors cross-talk. Steroids. 2020 Jan;153:108508. doi: 10.1016/j.steroids.2019.108508. Epub 2019 Oct 3.
147 Pharmacologic profiling of human and rat cytochrome P450 1A1 and 1A2 induction and competition. Arch Toxicol. 2008 Dec;82(12):909-21.
148 Effect of CYP1A1 gene polymorphisms on estrogen metabolism and bone density. J Bone Miner Res. 2005 Feb;20(2):232-9. doi: 10.1359/JBMR.041110. Epub 2004 Nov 16.
149 Increased sensitivity for troglitazone-induced cytotoxicity using a human in vitro co-culture model. Toxicol In Vitro. 2009 Oct;23(7):1387-95.
150 Isoform-specific induction of a human aldo-keto reductase by polycyclic aromatic hydrocarbons (PAHs), electrophiles, and oxidative stress: implications for the alternative pathway of PAH activation catalyzed by human dihydrodiol dehydrogenase. Cancer Res. 1999 Feb 1;59(3):607-14.
151 Gene expression changes in human small airway epithelial cells exposed to Delta9-tetrahydrocannabinol. Toxicol Lett. 2005 Aug 14;158(2):95-107.
152 The metallohormone cadmium modulates AhR-associated gene expression in the small intestine of rats similar to ethinyl-estradiol. Arch Toxicol. 2013 Apr;87(4):633-43.
153 Evidence for a new human CYP1A1 regulation pathway involving PPAR-alpha and 2 PPRE sites. Gastroenterology. 2004 Nov;127(5):1436-45.
154 Gene expression after treatment with hydrogen peroxide, menadione, or t-butyl hydroperoxide in breast cancer cells. Cancer Res. 2002 Nov 1;62(21):6246-54.
155 Convergent transcriptional profiles induced by endogenous estrogen and distinct xenoestrogens in breast cancer cells. Carcinogenesis. 2006 Aug;27(8):1567-78.
156 Gene expression in endometrial cancer cells (Ishikawa) after short time high dose exposure to progesterone. Steroids. 2008 Jan;73(1):116-28.
157 Apoptosis contributes to the cytotoxicity induced by amodiaquine and its major metabolite N-desethylamodiaquine in hepatic cells. Toxicol In Vitro. 2020 Feb;62:104669. doi: 10.1016/j.tiv.2019.104669. Epub 2019 Oct 16.
158 Genetic variants contributing to daunorubicin-induced cytotoxicity. Cancer Res. 2008 May 1;68(9):3161-8. doi: 10.1158/0008-5472.CAN-07-6381.
159 Calcium pantothenate modulates gene expression in proliferating human dermal fibroblasts. Exp Dermatol. 2009 Nov;18(11):969-78. doi: 10.1111/j.1600-0625.2009.00884.x. Epub 2009 Apr 8.
160 Red clover aryl hydrocarbon receptor (AhR) and estrogen receptor (ER) agonists enhance genotoxic estrogen metabolism. Chem Res Toxicol. 2017 Nov 20;30(11):2084-2092.
161 Characteristics of P388/VMDRC.04, a simple, sensitive model for studying P-glycoprotein antagonists. Cancer Res. 1994 Feb 1;54(3):730-7.
162 Michaelis-Menten kinetic analysis of drugs of abuse to estimate their affinity to human P-glycoprotein. Toxicol Lett. 2013 Feb 27;217(2):137-42. doi: 10.1016/j.toxlet.2012.12.012. Epub 2012 Dec 27.
163 Editor's Highlight: PlacentalDisposition and Effects of Crizotinib: An Ex Vivo Study in the Isolated Dual-Side Perfused Human Cotyledon. Toxicol Sci. 2017 Jun 1;157(2):500-509. doi: 10.1093/toxsci/kfx063.
164 Functional evaluation of polymorphisms in the human ABCB1 gene and the impact on clinical responses of antiepileptic drugs. Pharmacogenet Genomics. 2008 May;18(5):390-402. doi: 10.1097/FPC.0b013e3282f85e36.
165 Cepharanthine potently enhances the sensitivity of anticancer agents in K562 cells. Cancer Sci. 2005 Jun;96(6):372-6. doi: 10.1111/j.1349-7006.2005.00057.x.
166 Clinical pharmacokinetic monitoring of itraconazole is warranted in only a subset of patients. Ther Drug Monit. 2005 Jun;27(3):322-33. doi: 10.1097/01.ftd.0000150135.22645.ea.
167 Evaluation of antipsychotic drugs as inhibitors of multidrug resistance transporter P-glycoprotein. Psychopharmacology (Berl). 2006 Sep;187(4):415-23. doi: 10.1007/s00213-006-0437-9. Epub 2006 Jun 30.
168 Actions of the selective protein kinase C inhibitor PKC412 on B-chronic lymphocytic leukemia cells in vitro. Haematologica. 2002 Feb;87(2):167-76.
169 Characterization of the ATPase activity of the Mr 170,000 to 180,000 membrane glycoprotein (P-glycoprotein) associated with multidrug resistance in K562/ADM cells. Cancer Res. 1988 Sep 1;48(17):4926-32.
170 Localization of breast cancer resistance protein (Bcrp) in endocrine organs and inhibition of its transport activity by steroid hormones. Cell Tissue Res. 2012 Aug;349(2):551-63. doi: 10.1007/s00441-012-1417-5. Epub 2012 May 13.
171 Pharmacogenetics of ABCG2 and adverse reactions to gefitinib. J Natl Cancer Inst. 2006 Dec 6;98(23):1739-42.
172 ABCG2 polymorphism is associated with the low-density lipoprotein cholesterol response to rosuvastatin. Clin Pharmacol Ther. 2010 May;87(5):558-62.
173 Ciprofloxacin mediates cancer stem cell phenotypes in lung cancer cells through caveolin-1-dependent mechanism. Chem Biol Interact. 2016 Apr 25;250:1-11.
174 Proteomic identification of differentially expressed proteins associated with the multiple drug resistance in methotrexate-resistant human breast cancer cells. Int J Oncol. 2014 Jul;45(1):448-58.
175 Activation of beta-catenin signalling by GSK-3 inhibition increases p-glycoprotein expression in brain endothelial cells. J Neurochem. 2008 Aug;106(4):1855-65. doi: 10.1111/j.1471-4159.2008.05537.x. Epub 2008 Jul 4.
176 Differential gene expression in human hepatocyte cell lines exposed to the antiretroviral agent zidovudine. Arch Toxicol. 2014 Mar;88(3):609-23. doi: 10.1007/s00204-013-1169-3. Epub 2013 Nov 30.
177 Chronic imatinib mesylate exposure leads to reduced intracellular drug accumulation by induction of the ABCG2 (BCRP) and ABCB1 (MDR1) drug transport pumps. Cancer Biol Ther. 2005 Jul;4(7):747-52.
178 Inhibition of human phenol and estrogen sulfotransferase by certain non-steroidal anti-inflammatory agents. Curr Drug Metab. 2006 Oct;7(7):745-53.
179 Methotrexate induction of human sulfotransferases in Hep G2 and Caco-2 cells. J Appl Toxicol. 2005 Sep-Oct;25(5):354-60.
180 Development and validation of a fluorescence HPLC-based screening assay for inhibition of human estrogen sulfotransferase. Anal Biochem. 2006 Oct 1;357(1):85-92.
181 Solvent effect on cDNA-expressed human sulfotransferase (SULT) activities in vitro. Drug Metab Dispos. 2003 Nov;31(11):1300-5.
182 Folic acid supplementation dysregulates gene expression in lymphoblastoid cells--implications in nutrition. Biochem Biophys Res Commun. 2011 Sep 9;412(4):688-92. doi: 10.1016/j.bbrc.2011.08.027. Epub 2011 Aug 16.
183 Omics-based responses induced by bosentan in human hepatoma HepaRG cell cultures. Arch Toxicol. 2018 Jun;92(6):1939-1952.
184 CXCL14 downregulation in human keratinocytes is a potential biomarker for a novel in vitro skin sensitization test. Toxicol Appl Pharmacol. 2020 Jan 1;386:114828. doi: 10.1016/j.taap.2019.114828. Epub 2019 Nov 14.
185 A novel, integrated in vitro carcinogenicity test to identify genotoxic and non-genotoxic carcinogens using human lymphoblastoid cells. Arch Toxicol. 2018 Feb;92(2):935-951. doi: 10.1007/s00204-017-2102-y. Epub 2017 Nov 6.
186 A Gene Expression Biomarker Identifies Chemical Modulators of Estrogen Receptor in an MCF-7 Microarray Compendium. Chem Res Toxicol. 2021 Feb 15;34(2):313-329. doi: 10.1021/acs.chemrestox.0c00243. Epub 2021 Jan 6.
187 Utilization of CDKN1A/p21 gene for class discrimination of DNA damage-induced clastogenicity. Toxicology. 2014 Jan 6;315:8-16. doi: 10.1016/j.tox.2013.10.009. Epub 2013 Nov 6.
188 Transcriptome-based functional classifiers for direct immunotoxicity. Arch Toxicol. 2014 Mar;88(3):673-89.
189 Gene expression profile of multiple myeloma cell line treated by arsenic trioxide. J Huazhong Univ Sci Technolog Med Sci. 2007 Dec;27(6):646-9. doi: 10.1007/s11596-007-0606-z.
190 THC exposure of human iPSC neurons impacts genes associated with neuropsychiatric disorders. Transl Psychiatry. 2018 Apr 25;8(1):89. doi: 10.1038/s41398-018-0137-3.
191 Ouabain impairs cell migration, and invasion and alters gene expression of human osteosarcoma U-2 OS cells. Environ Toxicol. 2017 Nov;32(11):2400-2413. doi: 10.1002/tox.22453. Epub 2017 Aug 10.
192 Integrated assessment by multiple gene expression analysis of quercetin bioactivity on anticancer-related mechanisms in colon cancer cells in vitro. Eur J Nutr. 2005 Mar;44(3):143-56. doi: 10.1007/s00394-004-0503-1. Epub 2004 Apr 30.
193 Transcriptional and Metabolic Dissection of ATRA-Induced Granulocytic Differentiation in NB4 Acute Promyelocytic Leukemia Cells. Cells. 2020 Nov 5;9(11):2423. doi: 10.3390/cells9112423.
194 Expression profile analysis of human peripheral blood mononuclear cells in response to aspirin. Arch Immunol Ther Exp (Warsz). 2005 Mar-Apr;53(2):151-8.
195 Transcriptomics hit the target: monitoring of ligand-activated and stress response pathways for chemical testing. Toxicol In Vitro. 2015 Dec 25;30(1 Pt A):7-18.
196 Targeting hypoxic tumor cell viability with carbohydrate-based carbonic anhydrase IX and XII inhibitors. J Med Chem. 2011 Oct 13;54(19):6905-18.
197 A transcriptome-based classifier to identify developmental toxicants by stem cell testing: design, validation and optimization for histone deacetylase inhibitors. Arch Toxicol. 2015 Sep;89(9):1599-618.
198 Design, synthesis, and biological evaluation of novel carbohydrate-based sulfamates as carbonic anhydrase inhibitors. J Med Chem. 2011 Mar 10;54(5):1481-9.
199 DNA microarray analysis of vitamin D-induced gene expression in a human colon carcinoma cell line. Physiol Genomics. 2004 Apr 13;17(2):122-9. doi: 10.1152/physiolgenomics.00002.2003.
200 Human embryonic stem cell-derived test systems for developmental neurotoxicity: a transcriptomics approach. Arch Toxicol. 2013 Jan;87(1):123-43.
201 The effect of quercetin nanoparticle on cervical cancer progression by inducing apoptosis, autophagy and anti-proliferation via JAK2 suppression. Biomed Pharmacother. 2016 Aug;82:595-605. doi: 10.1016/j.biopha.2016.05.029. Epub 2016 Jun 9.
202 MS4A3-HSP27 target pathway reveals potential for haematopoietic disorder treatment in alimentary toxic aleukia. Cell Biol Toxicol. 2023 Feb;39(1):201-216. doi: 10.1007/s10565-021-09639-4. Epub 2021 Sep 28.
203 Paroxetine modulates immune responses by activating a JAK2/STAT3 signaling pathway. J Biochem Mol Toxicol. 2020 May;34(5):e22464. doi: 10.1002/jbt.22464. Epub 2020 Feb 5.
204 A comprehensive analysis of Wnt/beta-catenin signaling pathway-related genes and crosstalk pathways in the treatment of As2O3 in renal cancer. Ren Fail. 2018 Nov;40(1):331-339.
205 Amlodipine inhibits cell proliferation via PKD1-related pathway. Biochem Biophys Res Commun. 2008 May 2;369(2):376-81. doi: 10.1016/j.bbrc.2008.02.075. Epub 2008 Feb 25.
206 Differences in gene expression and alterations in cell cycle of acute myeloid leukemia cell lines after treatment with JAK inhibitors. Eur J Pharmacol. 2015 Oct 15;765:188-97. doi: 10.1016/j.ejphar.2015.08.037. Epub 2015 Aug 20.
207 Gingival Stromal Cells as an In Vitro Model: Cannabidiol Modulates Genes Linked With Amyotrophic Lateral Sclerosis. J Cell Biochem. 2017 Apr;118(4):819-828. doi: 10.1002/jcb.25757. Epub 2016 Nov 28.
208 Integrating multiple omics to unravel mechanisms of Cyclosporin A induced hepatotoxicity in vitro. Toxicol In Vitro. 2015 Apr;29(3):489-501.
209 DNA methylome-wide alterations associated with estrogen receptor-dependent effects of bisphenols in breast cancer. Clin Epigenetics. 2019 Oct 10;11(1):138. doi: 10.1186/s13148-019-0725-y.
210 Development of a neural teratogenicity test based on human embryonic stem cells: response to retinoic acid exposure. Toxicol Sci. 2011 Dec;124(2):370-7.
211 Cdk4/6 inhibition induces epithelial-mesenchymal transition and enhances invasiveness in pancreatic cancer cells. Mol Cancer Ther. 2012 Oct;11(10):2138-48. doi: 10.1158/1535-7163.MCT-12-0562. Epub 2012 Aug 6.
212 Quantitative phosphoproteomics reveal cellular responses from caffeine, coumarin and quercetin in treated HepG2 cells. Toxicol Appl Pharmacol. 2022 Aug 15;449:116110. doi: 10.1016/j.taap.2022.116110. Epub 2022 Jun 7.
213 Effects of ciglitazone and troglitazone on the proliferation of human stomach cancer cells. World J Gastroenterol. 2009 Jan 21;15(3):310-20.
214 The neuroprotective action of the mood stabilizing drugs lithium chloride and sodium valproate is mediated through the up-regulation of the homeodomain protein Six1. Toxicol Appl Pharmacol. 2009 Feb 15;235(1):124-34.
215 Mifepristone induced progesterone withdrawal reveals novel regulatory pathways in human endometrium. Mol Hum Reprod. 2007 Sep;13(9):641-54.
216 Interleukin-19 as a translational indicator of renal injury. Arch Toxicol. 2015 Jan;89(1):101-6.
217 Discovery of molecular mechanisms of neuroprotection using cell-based bioassays and oligonucleotide arrays. Physiol Genomics. 2002 Oct 29;11(2):45-52. doi: 10.1152/physiolgenomics.00064.2002.
218 Hypotensive shock and angio-oedema from angiotensin II receptor blocker: a class effect in spite of tripled tryptase values. J Intern Med. 2005 Oct;258(4):385-7. doi: 10.1111/j.1365-2796.2005.01547.x.
219 Dual inhibition of RET and FGFR4 restrains medullary thyroid cancer cell growth. Clin Cancer Res. 2005 Feb 1;11(3):1336-41.
220 Large-scale in silico and microarray-based identification of direct 1,25-dihydroxyvitamin D3 target genes. Mol Endocrinol. 2005 Nov;19(11):2685-95.
221 Selenium and vitamin E: cell type- and intervention-specific tissue effects in prostate cancer. J Natl Cancer Inst. 2009 Mar 4;101(5):306-20.
222 Transcriptional profiling of testosterone-regulated genes in the skeletal muscle of human immunodeficiency virus-infected men experiencing weight loss. J Clin Endocrinol Metab. 2007 Jul;92(7):2793-802. doi: 10.1210/jc.2006-2722. Epub 2007 Apr 17.
223 The proapoptotic effect of zoledronic acid is independent of either the bone microenvironment or the intrinsic resistance to bortezomib of myeloma cells and is enhanced by the combination with arsenic trioxide. Exp Hematol. 2011 Jan;39(1):55-65.
224 Global molecular effects of tocilizumab therapy in rheumatoid arthritis synovium. Arthritis Rheumatol. 2014 Jan;66(1):15-23.
225 Inhibition of prostate cancer cell colony formation by the flavonoid quercetin correlates with modulation of specific regulatory genes. Clin Diagn Lab Immunol. 2004 Jan;11(1):63-9. doi: 10.1128/cdli.11.1.63-69.2004.
226 Peroxisome proliferator-activated receptor ligands affect growth-related gene expression in human leukemic cells. J Pharmacol Exp Ther. 2003 Jun;305(3):932-42. doi: 10.1124/jpet.103.049098. Epub 2003 Mar 20.
227 Comparison of the gene expression profiles of monocytic versus granulocytic lineages of HL-60 leukemia cell differentiation by DNA microarray analysis. Life Sci. 2003 Aug 15;73(13):1705-19. doi: 10.1016/s0024-3205(03)00515-0.
228 Hypomethylation mediated by decreased DNMTs involves in the activation of proto-oncogene MPL in TK6 cells treated with hydroquinone. Toxicol Lett. 2012 Mar 25;209(3):239-45. doi: 10.1016/j.toxlet.2011.12.020. Epub 2012 Jan 8.
229 Thalidomide alters c-MYB and PIM-1 signaling in K-562 cells. Pharmacol Res. 2006 Aug;54(2):91-6. doi: 10.1016/j.phrs.2006.02.010. Epub 2006 Mar 8.
230 Development and validation of the TGx-HDACi transcriptomic biomarker to detect histone deacetylase inhibitors in human TK6 cells. Arch Toxicol. 2021 May;95(5):1631-1645. doi: 10.1007/s00204-021-03014-2. Epub 2021 Mar 26.
231 Changes in gene expression profiles of multiple myeloma cells induced by arsenic trioxide (ATO): possible mechanisms to explain ATO resistance in vivo. Br J Haematol. 2005 Mar;128(5):636-44.
232 Single-cell Transcriptome Mapping Identifies Common and Cell-type Specific Genes Affected by Acute Delta9-tetrahydrocannabinol in Humans. Sci Rep. 2020 Feb 26;10(1):3450. doi: 10.1038/s41598-020-59827-1.
233 Mitogen-activated protein kinases pathway is involved in physiological testosterone-induced tissue factor pathway inhibitor expression in endothelial cells. Blood Coagul Fibrinolysis. 2010 Jul;21(5):420-4. doi: 10.1097/MBC.0b013e328337b475.
234 Characterization of formaldehyde's genotoxic mode of action by gene expression analysis in TK6 cells. Arch Toxicol. 2013 Nov;87(11):1999-2012.
235 Gene expression signatures after ethanol exposure in differentiating embryoid bodies. Toxicol In Vitro. 2018 Feb;46:66-76.
236 Oxidative stress modulates theophylline effects on steroid responsiveness. Biochem Biophys Res Commun. 2008 Dec 19;377(3):797-802.
237 A genomic approach to predict synergistic combinations for breast cancer treatment. Pharmacogenomics J. 2013 Feb;13(1):94-104. doi: 10.1038/tpj.2011.48. Epub 2011 Nov 15.
238 delta-Aminolevulinate dehydratase activity and oxidative stress during melphalan and cyclophosphamide-BCNU-etoposide (CBV) conditioning regimens in autologous bone marrow transplantation patients. Pharmacol Res. 2009 Apr;59(4):279-84.
239 Acute hypersensitivity of pluripotent testicular cancer-derived embryonal carcinoma to low-dose 5-aza deoxycytidine is associated with global DNA Damage-associated p53 activation, anti-pluripotency and DNA demethylation. PLoS One. 2012;7(12):e53003. doi: 10.1371/journal.pone.0053003. Epub 2012 Dec 27.
240 Cannabidiol enhances cytotoxicity of anti-cancer drugs in human head and neck squamous cell carcinoma. Sci Rep. 2020 Nov 26;10(1):20622. doi: 10.1038/s41598-020-77674-y.
241 Analysis of estrogen agonism and antagonism of tamoxifen, raloxifene, and ICI182780 in endometrial cancer cells: a putative role for the epidermal growth factor receptor ligand amphiregulin. J Soc Gynecol Investig. 2005 Oct;12(7):e55-67.
242 Ligand-dependent activation of the epidermal growth factor receptor by secondary bile acids in polarizing colon cancer cells. Surgery. 2005 Sep;138(3):415-21. doi: 10.1016/j.surg.2005.06.030.
243 Retinoid-induced epidermal hyperplasia is mediated by epidermal growth factor receptor activation via specific induction of its ligands heparin-binding EGF and amphiregulin in human skin in vivo. J Invest Dermatol. 2006 Apr;126(4):732-9. doi: 10.1038/sj.jid.5700202.
244 Effects of chlorpromazine with and without UV irradiation on gene expression of HepG2 cells. Mutat Res. 2005 Aug 4;575(1-2):47-60. doi: 10.1016/j.mrfmmm.2005.03.002. Epub 2005 Apr 26.
245 Amphiregulin is a vitamin D3 target gene in squamous cell and breast carcinoma. Biochem Biophys Res Commun. 2001 Mar 9;281(4):1051-6. doi: 10.1006/bbrc.2001.4466.
246 Characterization of the weak estrogen receptor alpha agonistic activity of exemestane. Breast Cancer Res Treat. 2009 Aug;116(3):461-70. doi: 10.1007/s10549-008-0151-x. Epub 2008 Aug 3.
247 Estrogen regulation in human breast cancer cells of new downstream gene targets involved in estrogen metabolism, cell proliferation and cell transformation. J Mol Endocrinol. 2004 Apr;32(2):397-414.
248 Essential role of cell cycle regulatory genes p21 and p27 expression in inhibition of breast cancer cells by arsenic trioxide. Med Oncol. 2011 Dec;28(4):1225-54.
249 Identification of vitamin D3 target genes in human breast cancer tissue. J Steroid Biochem Mol Biol. 2016 Nov;164:90-97.
250 Beta-carotene and apocarotenals promote retinoid signaling in BEAS-2B human bronchioepithelial cells. Arch Biochem Biophys. 2006 Nov 1;455(1):48-60.
251 Chemokine stromal cell-derived factor-1 induction by C/EBPbeta activation is associated with all-trans-retinoic acid-induced leukemic cell differentiation. J Leukoc Biol. 2007 Nov;82(5):1332-9. doi: 10.1189/jlb.1106697. Epub 2007 Jul 26.
252 How benzene and its metabolites affect human marrow derived mesenchymal stem cells. Toxicol Lett. 2012 Oct 17;214(2):145-53. doi: 10.1016/j.toxlet.2012.08.015. Epub 2012 Aug 30.
253 Integrative "-Omics" analysis in primary human hepatocytes unravels persistent mechanisms of cyclosporine A-induced cholestasis. Chem Res Toxicol. 2016 Dec 19;29(12):2164-2174.
254 Sevoflurane but not propofol enhances ovarian cancer cell biology through regulating cellular metabolic and signaling mechanisms. Cell Biol Toxicol. 2023 Aug;39(4):1395-1411. doi: 10.1007/s10565-022-09766-6. Epub 2022 Oct 8.
255 The platelet P2Y12 receptor contributes to granule secretion through Ephrin A4 receptor. Platelets. 2012;23(8):617-25. doi: 10.3109/09537104.2011.645924. Epub 2012 Jan 24.
256 Microarray analysis of H2O2-, HNE-, or tBH-treated ARPE-19 cells. Free Radic Biol Med. 2002 Nov 15;33(10):1419-32.
257 Retinoic acid-induced downmodulation of telomerase activity in human cancer cells. Exp Mol Pathol. 2005 Oct;79(2):108-17.
258 Comparison of base-line and chemical-induced transcriptomic responses in HepaRG and RPTEC/TERT1 cells using TempO-Seq. Arch Toxicol. 2018 Aug;92(8):2517-2531.
259 Monitoring of deiodinase deficiency based on transcriptomic responses in SH-SY5Y cells. Arch Toxicol. 2013 Jun;87(6):1103-13. doi: 10.1007/s00204-013-1018-4. Epub 2013 Feb 10.
260 Expression of the helix-loop-helix protein inhibitor of DNA binding-1 (ID-1) is activated by all-trans retinoic acid in normal human keratinocytes. Toxicol Appl Pharmacol. 2006 Aug 1;214(3):219-29. doi: 10.1016/j.taap.2005.12.015. Epub 2006 Feb 21.
261 Antirheumatic drug response signatures in human chondrocytes: potential molecular targets to stimulate cartilage regeneration. Arthritis Res Ther. 2009;11(1):R15.
262 The RET oncogene is a critical component of transcriptional programs associated with retinoic acid-induced differentiation in neuroblastoma. Mol Cancer Ther. 2007 Apr;6(4):1300-9.
263 Expression profile analysis of colon cancer cells in response to sulindac or aspirin. Biochem Biophys Res Commun. 2002 Mar 29;292(2):498-512.
264 Identification of transcriptome signatures and biomarkers specific for potential developmental toxicants inhibiting human neural crest cell migration. Arch Toxicol. 2016 Jan;90(1):159-80.
265 Arsenic suppresses gene expression in promyelocytic leukemia cells partly through Sp1 oxidation. Blood. 2005 Jul 1;106(1):304-10.
266 Quercetin induced cell apoptosis and altered gene expression in AGS human gastric cancer cells. Environ Toxicol. 2018 Nov;33(11):1168-1181. doi: 10.1002/tox.22623. Epub 2018 Aug 27.
267 Bone marrow osteoblast damage by chemotherapeutic agents. PLoS One. 2012;7(2):e30758. doi: 10.1371/journal.pone.0030758. Epub 2012 Feb 17.
268 Identification of selective inhibitors of cancer stem cells by high-throughput screening. Cell. 2009 Aug 21;138(4):645-659. doi: 10.1016/j.cell.2009.06.034. Epub 2009 Aug 13.
269 Identification by automated screening of a small molecule that selectively eliminates neural stem cells derived from hESCs but not dopamine neurons. PLoS One. 2009 Sep 23;4(9):e7155.
270 Identification of mechanisms of action of bisphenol a-induced human preadipocyte differentiation by transcriptional profiling. Obesity (Silver Spring). 2014 Nov;22(11):2333-43.
271 Epigenetic changes in individuals with arsenicosis. Chem Res Toxicol. 2011 Feb 18;24(2):165-7. doi: 10.1021/tx1004419. Epub 2011 Feb 4.
272 Definition of transcriptome-based indices for quantitative characterization of chemically disturbed stem cell development: introduction of the STOP-Toxukn and STOP-Toxukk tests. Arch Toxicol. 2017 Feb;91(2):839-864.
273 Effects of lithium and valproic acid on gene expression and phenotypic markers in an NT2 neurosphere model of neural development. PLoS One. 2013;8(3):e58822.
274 Gene expression profiling in Ishikawa cells: a fingerprint for estrogen active compounds. Toxicol Appl Pharmacol. 2009 Apr 1;236(1):85-96.
275 Dissecting progressive stages of 5-fluorouracil resistance in vitro using RNA expression profiling. Int J Cancer. 2004 Nov 1;112(2):200-12. doi: 10.1002/ijc.20401.
276 Differential modulation of PI3-kinase/Akt pathway during all-trans retinoic acid- and Am80-induced HL-60 cell differentiation revealed by DNA microarray analysis. Biochem Pharmacol. 2004 Dec 1;68(11):2177-86.
277 Mitochondrial Uncoupling Induces Epigenome Remodeling and Promotes Differentiation in Neuroblastoma. Cancer Res. 2023 Jan 18;83(2):181-194. doi: 10.1158/0008-5472.CAN-22-1029.
278 DNA methylation inhibits p53-mediated survivin repression. Oncogene. 2009 May 14;28(19):2046-50. doi: 10.1038/onc.2009.62. Epub 2009 Apr 13.
279 Persistent and non-persistent changes in gene expression result from long-term estrogen exposure of MCF-7 breast cancer cells. J Steroid Biochem Mol Biol. 2011 Feb;123(3-5):140-50.
280 Ethyl carbamate induces cell death through its effects on multiple metabolic pathways. Chem Biol Interact. 2017 Nov 1;277:21-32.
281 Endoplasmic reticulum stress contributes to arsenic trioxide-induced intrinsic apoptosis in human umbilical and bone marrow mesenchymal stem cells. Environ Toxicol. 2016 Mar;31(3):314-28.
282 Estrogen-like activity of metals in MCF-7 breast cancer cells. Endocrinology. 2003 Jun;144(6):2425-36. doi: 10.1210/en.2002-221054.
283 Cross-talk between non-genomic and genomic signalling pathways--distinct effect profiles of environmental estrogens. Toxicol Appl Pharmacol. 2010 Jun 1;245(2):160-70. doi: 10.1016/j.taap.2010.02.015. Epub 2010 Mar 4.
284 Bidirectional cross talk between ERalpha and EGFR signalling pathways regulates tamoxifen-resistant growth. Breast Cancer Res Treat. 2006 Mar;96(2):131-46. doi: 10.1007/s10549-005-9070-2. Epub 2005 Oct 27.
285 Sensitivity of human dental pulp cells to eighteen chemical agents used for endodontic treatments in dentistry. Odontology. 2013 Jan;101(1):43-51.
286 The dual ErbB1/ErbB2 inhibitor, lapatinib (GW572016), cooperates with tamoxifen to inhibit both cell proliferation- and estrogen-dependent gene expression in antiestrogen-resistant breast cancer. Cancer Res. 2005 Jan 1;65(1):18-25.
287 Antitumoral activity of liraglutide, a new DNMT inhibitor in breast cancer cells in vitro and in vivo. Chem Biol Interact. 2021 Nov 1;349:109641. doi: 10.1016/j.cbi.2021.109641. Epub 2021 Sep 14.
288 Estrogen receptor alpha mediates the proliferative but not the cytotoxic dose-dependent effects of two major phytoestrogens on human breast cancer cells. Mol Pharmacol. 2001 Sep;60(3):595-602.
289 Novel retinoic acid metabolism blocking agents have potent inhibitory activities on human breast cancer cells and tumour growth. Br J Cancer. 2007 Apr 23;96(8):1204-15. doi: 10.1038/sj.bjc.6603705. Epub 2007 Mar 27.
290 [Arsenic trioxide restores ER expression in ER-negative human breast cancer cells and its treatment efficacy in combination with tamoxifen in xenografts in nude mice]. Zhonghua Zhong Liu Za Zhi. 2012 Sep;34(9):645-51. doi: 10.3760/cma.j.issn.0253-3766.2012.09.002.
291 Ramipril inhibits in vitro human mesangial cell proliferation and platelet-derived growth factor expression. Exp Nephrol. 1999 May-Jun;7(3):229-35. doi: 10.1159/000020606.
292 Functional gene expression profile underlying methotrexate-induced senescence in human colon cancer cells. Tumour Biol. 2011 Oct;32(5):965-76.
293 Retinoic acid receptor alpha amplifications and retinoic acid sensitivity in breast cancers. Clin Breast Cancer. 2013 Oct;13(5):401-8.
294 Effects of folate deficiency on gene expression in the apoptosis and cancer pathways in colon cancer cells. Carcinogenesis. 2006 May;27(5):916-24. doi: 10.1093/carcin/bgi312. Epub 2005 Dec 16.
295 Resveratrol modulates the phosphoinositide 3-kinase pathway through an estrogen receptor alpha-dependent mechanism: relevance in cell proliferation. Int J Cancer. 2004 Mar 20;109(2):167-73. doi: 10.1002/ijc.11720.
296 Evaluation of an imaging-based in vitro screening platform for estrogenic activity with OECD reference chemicals. Toxicol In Vitro. 2022 Jun;81:105348. doi: 10.1016/j.tiv.2022.105348. Epub 2022 Mar 18.
297 Estrogenic activities of Ginkgo biloba extracts. Life Sci. 2004 Jan 30;74(11):1325-35. doi: 10.1016/j.lfs.2003.06.045.
298 Arsenic induces functional re-expression of estrogen receptor by demethylation of DNA in estrogen receptor-negative human breast cancer. PLoS One. 2012;7(4):e35957. doi: 10.1371/journal.pone.0035957. Epub 2012 Apr 27.
299 Co-culture of primary human mammary fibroblasts and MCF-7 cells as an in vitro breast cancer model. Toxicol Sci. 2005 Feb;83(2):257-63.
300 Serum distribution of the major metabolites of norgestimate in relation to its pharmacological properties. Contraception. 2003 Feb;67(2):93-9. doi: 10.1016/s0010-7824(02)00473-0.
301 Monosaccharide-induced lipogenesis regulates the human hepatic sex hormone-binding globulin gene. J Clin Invest. 2007 Dec;117(12):3979-87. doi: 10.1172/JCI32249.
302 Reproductive effects of valproate, carbamazepine, and oxcarbazepine in men with epilepsy. Neurology. 2001 Jan 9;56(1):31-6. doi: 10.1212/wnl.56.1.31.
303 Testosterone or 17{beta}-estradiol exposure reveals sex-specific effects on glucose and lipid metabolism in human myotubes. J Endocrinol. 2011 Aug;210(2):219-29. doi: 10.1530/JOE-10-0497. Epub 2011 Jun 1.
304 Human sex hormone-binding globulin binding affinities of 125 structurally diverse chemicals and comparison with their binding to androgen receptor, estrogen receptor, and -fetoprotein. Toxicol Sci. 2015 Feb;143(2):333-48. doi: 10.1093/toxsci/kfu231. Epub 2014 Oct 27.
305 Effects of the environmental estrogens bisphenol A, o,p'-DDT, p-tert-octylphenol and coumestrol on apoptosis induction, cell proliferation and the expression of estrogen sensitive molecular parameters in the human breast cancer cell line MCF-7. J Steroid Biochem Mol Biol. 2002 Jan;80(1):61-70. doi: 10.1016/s0960-0760(01)00173-x.
306 Conception and pharmacodynamic profile of drospirenone. Steroids. 2003 Nov;68(10-13):891-905. doi: 10.1016/j.steroids.2003.08.008.
307 Biological activity of all-trans-retinoic acid with and without tamoxifen and alpha-interferon 2a in breast cancer patients. Int J Oncol. 2000 Nov;17(5):991-1000. doi: 10.3892/ijo.17.5.991.
308 Tibolone and its metabolites enhance tissue factor and PAI-1 expression in human endometrial stromal cells: Evidence of progestogenic effects. Steroids. 2005 Nov;70(12):840-5. doi: 10.1016/j.steroids.2005.04.010.
309 Expression of estrogen-, progesterone-, and androgen-responsive genes in MCF-7 and MDA-MB-231 cells treated with o,p'-DDT, p,p'-DDT, or endosulfan. J Biochem Mol Toxicol. 2021 Jun;35(6):1-8. doi: 10.1002/jbt.22773. Epub 2021 Mar 16.
310 A comparative study of the effect of raloxifene and gosereline on uterine leiomyoma volume changes and estrogen receptor, progesterone receptor, bcl-2 and p53 expression immunohistochemically in premenopausal women. Eur J Obstet Gynecol Reprod Biol. 2007 Nov;135(1):94-103. doi: 10.1016/j.ejogrb.2006.07.042. Epub 2006 Sep 14.
311 Serum free BG-1 cell proliferation assay: a sensitive method for determining organochlorine pesticide estrogen receptor activation at the nanomolar range. Toxicol In Vitro. 2006 Apr;20(3):382-94. doi: 10.1016/j.tiv.2005.08.016. Epub 2005 Oct 19.
312 Down-regulation of intratumoral aromatase messenger RNA levels by docetaxel in human breast cancers. Clin Cancer Res. 2004 Dec 15;10(24):8163-9.
313 Retinoic acid can induce markers of endocrine transdifferentiation in pancreatic ductal adenocarcinoma: preliminary observations from an in vitro cell line model. J Clin Pathol. 2006 Jun;59(6):603-10. doi: 10.1136/jcp.2005.032003. Epub 2006 Feb 10.
314 [Toxic effects of aluminum on human embryonic cerebral neurocytes in vitro studies]. Zhonghua Yu Fang Yi Xue Za Zhi. 2000 Mar;34(2):106-8.
315 Biological specificity of CDK4/6 inhibitors: dose response relationship, in vivo signaling, and composite response signature. Oncotarget. 2017 Jul 4;8(27):43678-43691. doi: 10.18632/oncotarget.18435.
316 S100P is selectively upregulated in tumor cell lines challenged with DNA cross-linking agents. Leuk Res. 2005 Oct;29(10):1181-90. doi: 10.1016/j.leukres.2005.03.012.
317 Comparative gene expression analysis of a chronic myelogenous leukemia cell line resistant to cyclophosphamide using oligonucleotide arrays and response to tyrosine kinase inhibitors. Leuk Res. 2007 Nov;31(11):1511-20.
318 Extracellular ATP drives breast cancer cell migration and metastasis via S100A4 production by cancer cells and fibroblasts. Cancer Lett. 2018 Aug 28;430:1-10. doi: 10.1016/j.canlet.2018.04.043. Epub 2018 May 5.
319 Treatment with anticancer agents induces dysregulation of specific Wnt signaling pathways in human ovarian luteinized granulosa cells in vitro. Toxicol Sci. 2013 Nov;136(1):183-92. doi: 10.1093/toxsci/kft175. Epub 2013 Aug 16.
320 Progesterone increases csk homologous kinase in HMC-1560 human mast cells and reduces cell proliferation. J Cell Biochem. 2007 Dec 1;102(5):1271-80. doi: 10.1002/jcb.21357.
321 Cannabidiol upregulates melanogenesis through CB1 dependent pathway by activating p38 MAPK and p42/44 MAPK. Chem Biol Interact. 2017 Aug 1;273:107-114. doi: 10.1016/j.cbi.2017.06.005. Epub 2017 Jun 7.
322 Sertraline, an antidepressant, induces apoptosis in hepatic cells through the mitogen-activated protein kinase pathway. Toxicol Sci. 2014 Feb;137(2):404-15. doi: 10.1093/toxsci/kft254. Epub 2013 Nov 5.
323 Growth stimulation of human pulmonary adenocarcinoma cells and small airway epithelial cells by beta-carotene via activation of cAMP, PKA, CREB and ERK1/2. Int J Cancer. 2006 Mar 15;118(6):1370-80. doi: 10.1002/ijc.21537.
324 Estrogen and pure antiestrogen fulvestrant (ICI 182 780) augment cell-matrigel adhesion of MCF-7 breast cancer cells through a novel G protein coupled estrogen receptor (GPR30)-to-calpain signaling axis. Toxicol Appl Pharmacol. 2014 Mar 1;275(2):176-81. doi: 10.1016/j.taap.2014.01.005. Epub 2014 Jan 17.
325 Inhibition of activator protein 1 by barbiturates is mediated by differential effects on mitogen-activated protein kinases and the small G proteins ras and rac-1. J Pharmacol Exp Ther. 2004 Dec;311(3):1232-40. doi: 10.1124/jpet.104.071332. Epub 2004 Jul 19.
326 Growth of hormone-dependent MCF-7 breast cancer cells is promoted by constitutive caveolin-1 whose expression is lost in an EGF-R-mediated manner during development of tamoxifen resistance. Breast Cancer Res Treat. 2010 Feb;119(3):575-91. doi: 10.1007/s10549-009-0355-8. Epub 2009 Mar 15.
327 Effect of histamine H1 receptor antagonists on TARC/CCL17 and MDC/CCL22 production from CD14+ cells induced by antigenic stimulation in vitro. Int Arch Allergy Immunol. 2011;155(1):38-51. doi: 10.1159/000318720. Epub 2010 Nov 25.
328 SIRT3 Mediates the Antioxidant Effect of Hydrogen Sulfide in Endothelial Cells. Antioxid Redox Signal. 2016 Feb 20;24(6):329-43. doi: 10.1089/ars.2015.6331. Epub 2015 Nov 10.
329 Downregulation of mitogen-activated protein kinases (MAPKs) in chronic ethanol-induced fatty liver. Toxicol Mech Methods. 2020 Jul;30(6):407-416. doi: 10.1080/15376516.2020.1747126. Epub 2020 Apr 1.
330 A unique mechanism of beta-blocker action: carvedilol stimulates beta-arrestin signaling. Proc Natl Acad Sci U S A. 2007 Oct 16;104(42):16657-62. doi: 10.1073/pnas.0707936104. Epub 2007 Oct 9.
331 The stent-eluting drugs sirolimus and paclitaxel suppress healing of the endothelium by induction of autophagy. Am J Pathol. 2009 Nov;175(5):2226-34.
332 Modulation of apoptosis in HaCaT keratinocytes via differential regulation of ERK signaling pathway by flavonoids. J Biol Chem. 2005 Sep 9;280(36):31498-507. doi: 10.1074/jbc.M505537200. Epub 2005 Jul 13.
333 Cannabidiol Modulates the Immunophenotype and Inhibits the Activation of the Inflammasome in Human Gingival Mesenchymal Stem Cells. Front Physiol. 2016 Nov 24;7:559. doi: 10.3389/fphys.2016.00559. eCollection 2016.
334 Inhibition of cholesterol metabolism underlies synergy between mTOR pathway inhibition and chloroquine in bladder cancer cells. Oncogene. 2016 Aug 25;35(34):4518-28. doi: 10.1038/onc.2015.511. Epub 2016 Feb 8.
335 Nicotine-induced survival signaling in lung cancer cells is dependent on their p53 status while its down-regulation by curcumin is independent. Mol Cancer. 2010 Aug 20;9:220.
336 Role of miRNA in the regulation of cannabidiol-mediated apoptosis in neuroblastoma cells. Oncotarget. 2019 Jan 1;10(1):45-59. doi: 10.18632/oncotarget.26534. eCollection 2019 Jan 1.
337 -Carotene Induces Apoptosis in Human Esophageal Squamous Cell Carcinoma Cell Lines via the Cav-1/AKT/NF-B Signaling Pathway. J Biochem Mol Toxicol. 2016 Mar;30(3):148-57. doi: 10.1002/jbt.21773. Epub 2016 Jan 6.
338 Dihydromyricetin suppresses tumor growth via downregulation of the EGFR/Akt/survivin signaling pathway. J Biochem Mol Toxicol. 2023 Jun;37(6):e23328. doi: 10.1002/jbt.23328. Epub 2023 Feb 19.
339 Oxidative stress induces parallel autophagy and mitochondria dysfunction in human glioma U251 cells. Toxicol Sci. 2009 Aug;110(2):376-88. doi: 10.1093/toxsci/kfp101. Epub 2009 May 18.
340 Effect of toll-like receptor 7 and 9 targeted therapy to prevent the development of hepatocellular carcinoma. Liver Int. 2015 Mar;35(3):1063-76. doi: 10.1111/liv.12626. Epub 2014 Jul 30.
341 Low-expressional IGF1 mediated methimazole-induced liver developmental toxicity in fetal mice. Toxicology. 2018 Sep 1;408:70-79. doi: 10.1016/j.tox.2018.07.004. Epub 2018 Jul 7.
342 Ribavirin augments doxorubicin's efficacy in human hepatocellular carcinoma through inhibiting doxorubicin-induced eIF4E activation. J Biochem Mol Toxicol. 2018 Jan;32(1). doi: 10.1002/jbt.22007. Epub 2017 Nov 7.
343 Different apoptosis ratios and gene expressions in two human cell lines after sevoflurane anaesthesia. Acta Anaesthesiol Scand. 2009 Oct;53(9):1192-9. doi: 10.1111/j.1399-6576.2009.02036.x. Epub 2009 Jun 30.
344 [Mechanisms underlying the effect of arsenic trioxide on proliferation inhibition and apoptosis induction in myeloma cell line u266]. Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2007 Oct;15(5):982-5.
345 Lovastatin lactone elicits human lung cancer cell apoptosis via a COX-2/PPAR-dependent pathway. Oncotarget. 2016 Mar 1;7(9):10345-62. doi: 10.18632/oncotarget.7213.
346 Induction of apoptosis by cidofovir in human papillomavirus (HPV)-positive cells. Oncol Res. 2000;12(9-10):397-408. doi: 10.3727/096504001108747855.
347 Comparison of burst of reactive oxygen species and activation of caspase-3 in apoptosis of K562 and HL-60 cells induced by docetaxel. Cancer Lett. 2004 Oct 8;214(1):103-13. doi: 10.1016/j.canlet.2004.03.047.
348 Induction of mitochondrial manganese superoxide dismutase confers resistance to apoptosis in acute myeloblastic leukaemia cells exposed to etoposide. Br J Haematol. 2000 Mar;108(3):574-81. doi: 10.1046/j.1365-2141.2000.01852.x.
349 Cisplatin-enhanced sensitivity of glioblastoma multiforme U251 cells to adenovirus-delivered TRAIL in vitro. Tumour Biol. 2010 Dec;31(6):613-22. doi: 10.1007/s13277-010-0077-x. Epub 2010 Jul 11.
350 Insulin-like growth factor I is the key growth factor in serum that protects neuroblastoma cells from hyperosmotic-induced apoptosis. J Cell Physiol. 2000 Jan;182(1):24-32. doi: 10.1002/(SICI)1097-4652(200001)182:1<24::AID-JCP3>3.0.CO;2-6.
351 mRNA expression analysis of a variety of apoptosis-related genes, including the novel gene of the BCL2-family, BCL2L12, in HL-60 leukemia cells after treatment with carboplatin and doxorubicin. Biol Chem. 2004 Nov;385(11):1099-103. doi: 10.1515/BC.2004.143.
352 Neurokinin-1 receptor (NK1R) inhibition sensitizes APL cells to anti-tumor effect of arsenic trioxide via restriction of NF-B axis: Shedding new light on resistance to Aprepitant. Int J Biochem Cell Biol. 2018 Oct;103:105-114. doi: 10.1016/j.biocel.2018.08.010. Epub 2018 Aug 23.
353 Consequences of the natural retinoid/retinoid X receptor ligands action in human breast cancer MDA-MB-231 cell line: Focus on functional proteomics. Toxicol Lett. 2017 Nov 5;281:26-34. doi: 10.1016/j.toxlet.2017.09.001. Epub 2017 Sep 5.
354 [Differential proteomic expression in human liver cells stimulated by hydroquinone]. Zhonghua Lao Dong Wei Sheng Zhi Ye Bing Za Zhi. 2006 Nov;24(11):658-61.
355 Genomic and proteomic analysis of the effects of cannabinoids on normal human astrocytes. Brain Res. 2008 Jan 29;1191:1-11.
356 Zoledronate dysregulates fatty acid metabolism in renal tubular epithelial cells to induce nephrotoxicity. Arch Toxicol. 2018 Jan;92(1):469-485.
357 Azosemide is more potent than bumetanide and various other loop diuretics to inhibit the sodium-potassium-chloride-cotransporter human variants hNKCC1A and hNKCC1B. Sci Rep. 2018 Jun 29;8(1):9877. doi: 10.1038/s41598-018-27995-w.
358 Using a customized DNA microarray for expression profiling of the estrogen-responsive genes to evaluate estrogen activity among natural estrogens and industrial chemicals. Environ Health Perspect. 2004 May;112(7):773-81. doi: 10.1289/ehp.6753.
359 Cannabidiol Effectively Promoted Cell Death in Bladder Cancer and the Improved Intravesical Adhesion Drugs Delivery Strategy Could Be Better Used for Treatment. Pharmaceutics. 2021 Sep 7;13(9):1415. doi: 10.3390/pharmaceutics13091415.
360 Sertraline induces endoplasmic reticulum stress in hepatic cells. Toxicology. 2014 Aug 1;322:78-88. doi: 10.1016/j.tox.2014.05.007. Epub 2014 May 24.
361 A model to identify novel targets involved in oxidative stress-induced apoptosis in human lung epithelial cells by RNA interference. Toxicol In Vitro. 2010 Feb;24(1):310-8. doi: 10.1016/j.tiv.2009.08.008. Epub 2009 Aug 23.
362 Nitric oxide inhibits execution of apoptosis at two distinct ATP-dependent steps upstream and downstream of mitochondrial cytochrome c release. Biochem Biophys Res Commun. 1999 Apr 29;258(1):215-21. doi: 10.1006/bbrc.1999.0491.
363 Palmitate increases the susceptibility of cells to drug-induced toxicity: an in vitro method to identify drugs with potential contraindications in patients with metabolic disease. Toxicol Sci. 2012 Oct;129(2):346-62. doi: 10.1093/toxsci/kfs208. Epub 2012 Jun 14.
364 Response rate of fibrosarcoma cells to cytotoxic drugs on the expression level correlates to the therapeutic response rate of fibrosarcomas and is mediated by regulation of apoptotic pathways. BMC Cancer. 2005 Jul 7;5:74. doi: 10.1186/1471-2407-5-74.
365 Simvastatin induces apoptosis and alters cytoskeleton in endometrial stromal cells. J Clin Endocrinol Metab. 2010 Jul;95(7):3453-9. doi: 10.1210/jc.2010-0072. Epub 2010 Apr 28.
366 The involvement of hepatic cytochrome P450s in the cytotoxicity of lapatinib. Toxicol Sci. 2023 Dec 21;197(1):69-78. doi: 10.1093/toxsci/kfad099.
367 From transient transcriptome responses to disturbed neurodevelopment: role of histone acetylation and methylation as epigenetic switch between reversible and irreversible drug effects. Arch Toxicol. 2014 Jul;88(7):1451-68.
368 Selenium binding protein 1 in ovarian cancer. Int J Cancer. 2006 May 15;118(10):2433-40. doi: 10.1002/ijc.21671.
369 Multiple microRNAs function as self-protective modules in acetaminophen-induced hepatotoxicity in humans. Arch Toxicol. 2018 Feb;92(2):845-858.
370 Identification of HMG-CoA reductase inhibitors as activators for human, mouse and rat constitutive androstane receptor. Drug Metab Dispos. 2005 Jul;33(7):924-9.
371 Bioactive terpenoids and flavonoids from Ginkgo biloba extract induce the expression of hepatic drug-metabolizing enzymes through pregnane X receptor, constitutive androstane receptor, and aryl hydrocarbon receptor-mediated pathways. Pharm Res. 2009 Apr;26(4):872-82.
372 Species-specific toxicity of diclofenac and troglitazone in primary human and rat hepatocytes. Chem Biol Interact. 2009 Apr 15;179(1):17-24.
373 Fetal bovine serum and human constitutive androstane receptor: evidence for activation of the SV23 splice variant by artemisinin, artemether, and arteether in a serum-free cell culture system. Toxicol Appl Pharmacol. 2014 Jun 1;277(2):221-30. doi: 10.1016/j.taap.2014.03.023. Epub 2014 Apr 12.
374 Constitutive androstane/active receptor is a target of retinoic acid receptor in humans. Biochem Pharmacol. 2010 Jul 1;80(1):129-35. doi: 10.1016/j.bcp.2010.02.023. Epub 2010 Mar 6.
375 Robustness testing and optimization of an adverse outcome pathway on cholestatic liver injury. Arch Toxicol. 2020 Apr;94(4):1151-1172. doi: 10.1007/s00204-020-02691-9. Epub 2020 Mar 10.
376 Expression and inducibility of cytochrome P450s (CYP1A1, 2B6, 2E1, 3A4) in human cord blood CD34(+) stem cell-derived differentiating neuronal cells. Toxicol Sci. 2012 Oct;129(2):392-410.
377 Teriflunomide is an indirect human constitutive androstane receptor (CAR) activator interacting with epidermal growth factor (EGF) signaling. Front Pharmacol. 2018 Oct 11;9:993.
378 Agonistic effects of diverse xenobiotics on the constitutive androstane receptor as detected in a recombinant yeast-cell assay. Toxicol In Vitro. 2018 Feb;46:335-349. doi: 10.1016/j.tiv.2017.09.014. Epub 2017 Sep 18.
379 Identification of estrogen-responsive genes by complementary deoxyribonucleic acid microarray and characterization of a novel early estrogen-induced gene: EEIG1. Mol Endocrinol. 2004 Feb;18(2):402-11. doi: 10.1210/me.2003-0202. Epub 2003 Nov 6.
380 Arsenite and cadmium promote the development of mammary tumors. Carcinogenesis. 2020 Jul 14;41(7):1005-1014. doi: 10.1093/carcin/bgz176.
381 Combined tamoxifen and gefitinib in non-small cell lung cancer shows antiproliferative effects. Biomed Pharmacother. 2010 Feb;64(2):88-92. doi: 10.1016/j.biopha.2009.06.010. Epub 2009 Oct 23.
382 Quercetin exerts bidirectional regulation effects on the efficacy of tamoxifen in estrogen receptor-positive breast cancer therapy: An in vitro study. Environ Toxicol. 2020 Nov;35(11):1179-1193. doi: 10.1002/tox.22983. Epub 2020 Jun 12.
383 Estrogenic effects of natural and synthetic compounds including tibolone assessed in Saccharomyces cerevisiae expressing the human estrogen alpha and beta receptors. FASEB J. 2006 Jul;20(9):1552-4. doi: 10.1096/fj.05-5413fje. Epub 2006 May 23.
384 Comparison of relative binding affinities to fish and mammalian estrogen receptors: the regulatory implications. Toxicol Lett. 2010 Feb 15;192(3):298-315. doi: 10.1016/j.toxlet.2009.11.004. Epub 2009 Nov 12.
385 Screening for estrogen and androgen receptor activities in 200 pesticides by in vitro reporter gene assays using Chinese hamster ovary cells. Environ Health Perspect. 2004 Apr;112(5):524-31. doi: 10.1289/ehp.6649.
386 Valproic acid and its derivatives enhanced estrogenic activity but not androgenic activity in a structure dependent manner. Reprod Toxicol. 2013 Dec;42:49-57. doi: 10.1016/j.reprotox.2013.07.019. Epub 2013 Jul 26.
387 Relationship between estrogen receptor-binding and estrogenic activities of environmental estrogens and suppression by flavonoids. Biosci Biotechnol Biochem. 2002 Jul;66(7):1479-87. doi: 10.1271/bbb.66.1479.
388 Arylpiperazines for management of benign prostatic hyperplasia: design, synthesis, quantitative structure-activity relationships, and pharmacokinetic studies. J Med Chem. 2011 Jan 13;54(1):302-11. doi: 10.1021/jm101163m. Epub 2010 Dec 3.
389 Cannabidiol induces antioxidant pathways in keratinocytes by targeting BACH1. Redox Biol. 2020 Jan;28:101321. doi: 10.1016/j.redox.2019.101321. Epub 2019 Sep 5.
390 An in vitro coculture system of human peripheral blood mononuclear cells with hepatocellular carcinoma-derived cells for predicting drug-induced liver injury. Arch Toxicol. 2021 Jan;95(1):149-168. doi: 10.1007/s00204-020-02882-4. Epub 2020 Aug 20.
391 Actinomycin D inhibits the expression of the cystine/glutamate transporter xCT via attenuation of CD133 synthesis in CD133(+) HCC. Chem Biol Interact. 2019 Aug 25;309:108713. doi: 10.1016/j.cbi.2019.06.026. Epub 2019 Jun 19.
392 Pharmacogenomic analysis of acute promyelocytic leukemia cells highlights CYP26 cytochrome metabolism in differential all-trans retinoic acid sensitivity. Blood. 2007 May 15;109(10):4450-60.
393 Delta9-tetrahydrocannabinol inhibits cytotrophoblast cell proliferation and modulates gene transcription. Mol Hum Reprod. 2006 May;12(5):321-33. doi: 10.1093/molehr/gal036. Epub 2006 Apr 5.
394 Drug-induced endoplasmic reticulum and oxidative stress responses independently sensitize toward TNF-mediated hepatotoxicity. Toxicol Sci. 2014 Jul;140(1):144-59. doi: 10.1093/toxsci/kfu072. Epub 2014 Apr 20.
395 Retinoic acid and its 4-oxo metabolites are functionally active in human skin cells in vitro. J Invest Dermatol. 2005 Jul;125(1):143-53.
396 Steroidogenic gene expression in H295R cells and the human adrenal gland: adrenotoxic effects of lindane in vitro. J Appl Toxicol. 2006 Nov-Dec;26(6):484-92.
397 Integrated 'omics analysis reveals new drug-induced mitochondrial perturbations in human hepatocytes. Toxicol Lett. 2018 Jun 1;289:1-13.
398 Characterization of human liver thermostable phenol sulfotransferase (SULT1A1) allozymes with 3,3',5-triiodothyronine as the substrate. J Endocrinol. 2001 Dec;171(3):525-32.
399 Enzymatic characterization and interspecies difference of phenol sulfotransferases, ST1A forms. Drug Metab Dispos. 2001 Mar;29(3):274-81.
400 Sulfation of benzyl alcohol by the human cytosolic sulfotransferases (SULTs): a systematic analysis. J Appl Toxicol. 2016 Sep;36(9):1090-4.
401 Minimal peroxide exposure of neuronal cells induces multifaceted adaptive responses. PLoS One. 2010 Dec 17;5(12):e14352. doi: 10.1371/journal.pone.0014352.
402 The H295R system for evaluation of endocrine-disrupting effects. Ecotoxicol Environ Saf. 2006 Nov;65(3):293-305.
403 Organotin compounds enhance 17beta-hydroxysteroid dehydrogenase type I activity in human choriocarcinoma JAr cells: potential promotion of 17beta-estradiol biosynthesis in human placenta. Biochem Pharmacol. 2006 Apr 28;71(9):1349-57.
404 Estrogenic endocrine disruptive components interfere with calcium handling and differentiation of human trophoblast cells. J Cell Biochem. 2003 Jul 1;89(4):755-70.
405 Effects of dutasteride on the expression of genes related to androgen metabolism and related pathway in human prostate cancer cell lines. Invest New Drugs. 2007 Oct;25(5):491-7.
406 Acetaminophen Modulates the Expression of Steroidogenesis-Associated Genes and Estradiol Levels in Human Placental JEG-3 Cells. Toxicol Sci. 2021 Jan 6;179(1):44-52. doi: 10.1093/toxsci/kfaa160.
407 Decreased levels of H3K9ac and H3K27ac in the promotor region of ovarian P450 aromatase mediated low estradiol synthesis in female offspring rats induced by prenatal nicotine exposure as well as in human granulosa cells after nicotine treatment. Food Chem Toxicol. 2019 Jun;128:256-266. doi: 10.1016/j.fct.2019.03.055. Epub 2019 Apr 6.
408 Effect of prenatal arsenic exposure on DNA methylation and leukocyte subpopulations in cord blood. Epigenetics. 2014 May;9(5):774-82. doi: 10.4161/epi.28153. Epub 2014 Feb 13.
409 Transcriptome and DNA methylome dynamics during triclosan-induced cardiomyocyte differentiation toxicity. Stem Cells Int. 2018 Oct 29;2018:8608327.
410 Highly conserved mouse and human brain sulfotransferases: molecular cloning, expression, and functional characterization. Gene. 2002 Feb 20;285(1-2):39-47. doi: 10.1016/s0378-1119(02)00431-6.
411 Metabolic patterns and biotransformation activities of resveratrol in human glioblastoma cells: relevance with therapeutic efficacies. PLoS One. 2011;6(11):e27484.
412 Air pollution and DNA methylation alterations in lung cancer: A systematic and comparative study. Oncotarget. 2017 Jan 3;8(1):1369-1391. doi: 10.18632/oncotarget.13622.
413 Cell-based two-dimensional morphological assessment system to predict cancer drug-induced cardiotoxicity using human induced pluripotent stem cell-derived cardiomyocytes. Toxicol Appl Pharmacol. 2019 Nov 15;383:114761. doi: 10.1016/j.taap.2019.114761. Epub 2019 Sep 15.
414 Effect of all-trans retinoic acid on sodium/iodide symporter expression, radioiodine uptake and gene expression profiles in a human anaplastic thyroid carcinoma cell line. Nucl Med Biol. 2006 Oct;33(7):875-82. doi: 10.1016/j.nucmedbio.2006.07.004.
415 In vitro and in vivo irinotecan-induced changes in expression profiles of cell cycle and apoptosis-associated genes in acute myeloid leukemia cells. Mol Cancer Ther. 2005 Jun;4(6):885-900.
416 Megadose vitamin C suppresses sulfoconjugation in human colon carcinoma cell line Caco-2. Toxicol In Vitro. 2011 Mar;25(2):500-4.
417 Insulin-like growth factors (IGF) I and II utilize different calcium signaling pathways in a primary human parathyroid cell culture model. World J Surg. 2006 Mar;30(3):333-45. doi: 10.1007/s00268-005-0339-8.
418 Quercetin regulates insulin like growth factor signaling and induces intrinsic and extrinsic pathway mediated apoptosis in androgen independent prostate cancer cells (PC-3). Mol Cell Biochem. 2010 Nov;344(1-2):173-84. doi: 10.1007/s11010-010-0540-4. Epub 2010 Jul 25.
419 Effect of aspirin on cell proliferation and differentiation of colon adenocarcinoma Caco-2 cells. Int J Cancer. 1997 Dec 10;73(6):880-4. doi: 10.1002/(sici)1097-0215(19971210)73:6<880::aid-ijc20>3.0.co;2-7.
420 Ethinylestradiol and testosterone have divergent effects on circulating IGF system components in adolescents with constitutional tall stature. Eur J Endocrinol. 2005 Apr;152(4):597-604. doi: 10.1530/eje.1.01880.
421 Periconceptional maternal folic acid use of 400 microg per day is related to increased methylation of the IGF2 gene in the very young child. PLoS One. 2009 Nov 16;4(11):e7845. doi: 10.1371/journal.pone.0007845.
422 Dasatinib reverses cancer-associated fibroblasts (CAFs) from primary lung carcinomas to a phenotype comparable to that of normal fibroblasts. Mol Cancer. 2010 Jun 27;9:168.
423 Molecular mechanisms controlling the rate and specificity of catechol O-methylation by human soluble catechol O-methyltransferase. Mol Pharmacol. 2001 Feb;59(2):393-402. doi: 10.1124/mol.59.2.393.
424 Effects of modafinil on the sleep EEG depend on Val158Met genotype of COMT. Sleep. 2010 Aug;33(8):1027-35. doi: 10.1093/sleep/33.8.1027.
425 Tolcapone increases plasma catecholamine levels in patients with Parkinson's disease. Parkinsonism Relat Disord. 2001 Apr;7(2):93-96. doi: 10.1016/s1353-8020(00)00027-4.
426 Gene microarray analysis of human renal cell carcinoma: the effects of HDAC inhibition and retinoid treatment. Cancer Biol Ther. 2008 Oct;7(10):1607-18.
427 PPARgamma controls CD1d expression by turning on retinoic acid synthesis in developing human dendritic cells. J Exp Med. 2006 Oct 2;203(10):2351-62.
428 Use of mRNA expression to detect the induction of drug metabolising enzymes in rat and human hepatocytes. Toxicol Appl Pharmacol. 2009 Feb 15;235(1):86-96.
429 Induction of CYP3As in HepG2 cells by several drugs. Association between induction of CYP3A4 and expression of glucocorticoid receptor. Biol Pharm Bull. 2003 Apr;26(4):510-7.
430 Human drug metabolism genes in parathion-and estrogen-treated breast cells. Int J Mol Med. 2007 Dec;20(6):875-81.
431 Dose- and time-dependent effects of phenobarbital on gene expression profiling in human hepatoma HepaRG cells. Toxicol Appl Pharmacol. 2009 Feb 1;234(3):345-60.
432 Transcriptional profiling of genes induced in the livers of patients treated with carbamazepine. Clin Pharmacol Ther. 2006 Nov;80(5):440-456.
433 Variability of CYP3A7 expression in human fetal liver. J Pharmacol Exp Ther. 2005 Aug;314(2):626-35. doi: 10.1124/jpet.105.086504. Epub 2005 Apr 21.
434 Participation of CYP2C8 and CYP3A4 in the N-demethylation of imatinib in human hepatic microsomes. Br J Pharmacol. 2010 Nov;161(5):1059-69. doi: 10.1111/j.1476-5381.2010.00946.x.
435 Bringing in vitro analysis closer to in vivo: studying doxorubicin toxicity and associated mechanisms in 3D human microtissues with PBPK-based dose modelling. Toxicol Lett. 2018 Sep 15;294:184-192.
436 Substrate specificity of human 3(20)alpha-hydroxysteroid dehydrogenase for neurosteroids and its inhibition by benzodiazepines. Biol Pharm Bull. 2002 Apr;25(4):441-5.
437 Progestins as inhibitors of the human 20-ketosteroid reductases, AKR1C1 and AKR1C3. Chem Biol Interact. 2011 May 30;191(1-3):227-33.
438 In-vivo effects of simvastatin and rosuvastatin on global gene expression in peripheral blood leucocytes in a human inflammation model. Pharmacogenet Genomics. 2008 Feb;18(2):109-20.
439 AKR1C3 as a potential target for the inhibitory effect of dietary flavonoids. Chem Biol Interact. 2009 Mar 16;178(1-3):138-44.
440 Rabbit dehydrogenase/reductase SDR family member 11 (DHRS11): Its identity with acetohexamide reductase with broad substrate specificity and inhibitor sensitivity, different from human DHRS11. Chem Biol Interact. 2019 May 25;305:12-20. doi: 10.1016/j.cbi.2019.03.026. Epub 2019 Mar 26.
441 Gene expression profile induced by arsenic trioxide in chronic lymphocytic leukemia cells reveals a central role for heme oxygenase-1 in apoptosis and regulation of matrix metalloproteinase-9. Oncotarget. 2016 Dec 13;7(50):83359-83377.
442 Differential expression of microRNAs and their predicted targets in renal cells exposed to amphotericin B and its complex with copper (II) ions. Toxicol Mech Methods. 2017 Sep;27(7):537-543. doi: 10.1080/15376516.2017.1333554. Epub 2017 Jun 8.
443 Retinoid-mediated stimulation of steroid sulfatase activity in myeloid leukemic cell lines requires RARalpha and RXR and involves the phosphoinositide 3-kinase and ERK-MAP kinase pathways. J Cell Biochem. 2006 Feb 1;97(2):327-50. doi: 10.1002/jcb.20579.
444 Synthesis and steroid sulphatase inhibitory activity of C19- and C21-steroidal derivatives bearing a benzyl-inhibiting group. Eur J Med Chem. 2001 Jul-Aug;36(7-8):659-71. doi: 10.1016/s0223-5234(01)01262-4.
445 Aromatase inhibition: translation into a successful therapeutic approach. Clin Cancer Res. 2005 Apr 15;11(8):2809-21. doi: 10.1158/1078-0432.CCR-04-2187.
446 Cannabidiol (CBD) but not tetrahydrocannabinol (THC) dysregulate in vitro decidualization of human endometrial stromal cells by disruption of estrogen signaling. Reprod Toxicol. 2020 Apr;93:75-82. doi: 10.1016/j.reprotox.2020.01.003. Epub 2020 Jan 14.
447 Effects of selective serotonin reuptake inhibitors on three sex steroids in two versions of the aromatase enzyme inhibition assay and in the H295R cell assay. Toxicol In Vitro. 2015 Oct;29(7):1729-35.
448 Synthesis and evaluation of (pyridylmethylene)tetrahydronaphthalenes/-indanes and structurally modified derivatives: potent and selective inhibitors of aldosterone synthase. J Med Chem. 2005 Mar 10;48(5):1563-75.
449 Comparative assessment of the inhibition of recombinant human CYP19 (aromatase) by azoles used in agriculture and as drugs for humans. Endocr Res. 2004 Aug;30(3):387-94.
450 Estrogen synthesis in human colon cancer epithelial cells. J Steroid Biochem Mol Biol. 1999 Dec 31;71(5-6):223-30.
451 Retinoids and retinol differentially regulate steroid biosynthesis in ovarian theca cells isolated from normal cycling women and women with polycystic ovary syndrome. J Clin Endocrinol Metab. 2005 Aug;90(8):4858-65. doi: 10.1210/jc.2005-0330. Epub 2005 May 24.
452 Cinnamic acid based thiazolidinediones inhibit human P450c17 and 3beta-hydroxysteroid dehydrogenase and improve insulin sensitivity independent of PPARgamma agonist activity. J Mol Endocrinol. 2004 Apr;32(2):425-36.
453 Use of organ culture to study the human fetal testis development: effect of retinoic acid. J Clin Endocrinol Metab. 2006 Jul;91(7):2696-703.
454 Inhibition of CYP17 expression by adrenal androgens and transforming growth factor beta in adrenocortical cells. Acta Biochim Pol. 2004;51(4):907-17.
455 Phosphorylation of CtBP1 by cAMP-dependent protein kinase modulates induction of CYP17 by stimulating partnering of CtBP1 and 2. J Biol Chem. 2008 Mar 14;283(11):6925-34. doi: 10.1074/jbc.M708432200. Epub 2008 Jan 9.
456 Effects of anticonvulsants on human p450c17 (17alpha-hydroxylase/17,20 lyase) and 3beta-hydroxysteroid dehydrogenase type 2. Epilepsia. 2005 Mar;46(3):444-8.
457 A fission yeast-based test system for the determination of IC50 values of anti-prostate tumor drugs acting on CYP21. J Enzyme Inhib Med Chem. 2006 Oct;21(5):547-56.
458 Arsenic targets Pin1 and cooperates with retinoic acid to inhibit cancer-driving pathways and tumor-initiating cells. Nat Commun. 2018 Aug 9;9(1):3069. doi: 10.1038/s41467-018-05402-2.
459 The psychoactive compound of Cannabis sativa, (9)-tetrahydrocannabinol (THC) inhibits the human trophoblast cell turnover. Toxicology. 2015 Aug 6;334:94-103. doi: 10.1016/j.tox.2015.06.005. Epub 2015 Jun 9.
460 The effects of desmethylimipramine on cyclic AMP-stimulated gene transcription in a model cell system. Biochem Pharmacol. 2005 Sep 1;70(5):762-9. doi: 10.1016/j.bcp.2005.06.012.
461 The genomic response of a human uterine endometrial adenocarcinoma cell line to 17alpha-ethynyl estradiol. Toxicol Sci. 2009 Jan;107(1):40-55.
462 Ornithine decarboxylase antizyme upregulates DNA-dependent protein kinase and enhances the nonhomologous end-joining repair of DNA double-strand breaks in human oral cancer cells. Biochemistry. 2007 Aug 7;46(31):8920-32. doi: 10.1021/bi7000328. Epub 2007 Jul 14.